JP5769504B2 - 医薬 - Google Patents

Info

Publication number

JP5769504B2

JP5769504B2 JP2011125191A JP2011125191A JP5769504B2 JP 5769504 B2 JP5769504 B2 JP 5769504B2 JP 2011125191 A JP2011125191 A JP 2011125191A JP 2011125191 A JP2011125191 A JP 2011125191A JP 5769504 B2 JP5769504 B2 JP 5769504B2

Authority

JP

Japan

Prior art keywords

group

alkyl group

alkyl

alkoxy

optionally

Prior art date

2010-06-04

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Fee Related

Links

• Espacenet
• Global Dossier
• Discuss

• 239000003814 drug Substances 0.000 title claims description 41
• 229940079593 drug Drugs 0.000 title claims description 13
• 125000000217 alkyl group Chemical group 0.000 claims description 573
• -1 piperazyl Chemical group 0.000 claims description 209
• 125000003545 alkoxy group Chemical group 0.000 claims description 207
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 197
• 125000004193 piperazinyl group Chemical group 0.000 claims description 112
• 125000002757 morpholinyl group Chemical group 0.000 claims description 101
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 99
• 229910052739 hydrogen Inorganic materials 0.000 claims description 97
• 239000001257 hydrogen Substances 0.000 claims description 97
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 88
• 125000002252 acyl group Chemical group 0.000 claims description 83
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 74
• 229910052736 halogen Inorganic materials 0.000 claims description 59
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 58
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 57
• 150000002367 halogens Chemical class 0.000 claims description 57
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 46
• 125000003277 amino group Chemical group 0.000 claims description 43
• 201000010099 disease Diseases 0.000 claims description 41
• 150000002431 hydrogen Chemical class 0.000 claims description 39
• 208000011580 syndromic disease Diseases 0.000 claims description 30
• 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 29
• 150000003839 salts Chemical class 0.000 claims description 28
• 125000005936 piperidyl group Chemical group 0.000 claims description 24
• 125000001476 phosphono group Chemical group [H]OP(*)(=O)O[H] 0.000 claims description 23
• 238000004519 manufacturing process Methods 0.000 claims description 22
• 125000004076 pyridyl group Chemical group 0.000 claims description 22
• 125000001589 carboacyl group Chemical group 0.000 claims description 21
• 125000002541 furyl group Chemical group 0.000 claims description 21
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 21
• 125000003226 pyrazolyl group Chemical group 0.000 claims description 21
• 125000000714 pyrimidinyl group Chemical group 0.000 claims description 21
• 125000001544 thienyl group Chemical group 0.000 claims description 21
• 125000004423 acyloxy group Chemical group 0.000 claims description 20
• 238000011282 treatment Methods 0.000 claims description 18
• 208000035475 disorder Diseases 0.000 claims description 16
• 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 16
• 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 claims description 15
• 125000004043 oxo group Chemical group O=* 0.000 claims description 15
• 125000005959 diazepanyl group Chemical group 0.000 claims description 14
• 125000005236 alkanoylamino group Chemical group 0.000 claims description 13
• 125000004691 alkyl thio carbonyl group Chemical group 0.000 claims description 13
• 239000003795 chemical substances by application Substances 0.000 claims description 13
• 206010008027 Cerebellar atrophy Diseases 0.000 claims description 12
• 230000007812 deficiency Effects 0.000 claims description 12
• 125000005961 oxazepanyl group Chemical group 0.000 claims description 12
• 125000001412 tetrahydropyranyl group Chemical group 0.000 claims description 12
• 230000001225 therapeutic effect Effects 0.000 claims description 12
• 206010003591 Ataxia Diseases 0.000 claims description 11
• 230000004770 neurodegeneration Effects 0.000 claims description 11
• 208000015122 neurodegenerative disease Diseases 0.000 claims description 11
• 230000000750 progressive effect Effects 0.000 claims description 11
• 125000002393 azetidinyl group Chemical group 0.000 claims description 10
• 125000002883 imidazolyl group Chemical group 0.000 claims description 10
• 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 claims description 10
• 125000006239 protecting group Chemical group 0.000 claims description 10
• 208000018737 Parkinson disease Diseases 0.000 claims description 9
• 230000005856 abnormality Effects 0.000 claims description 9
• 230000004898 mitochondrial function Effects 0.000 claims description 9
• 206010003694 Atrophy Diseases 0.000 claims description 7
• 239000004480 active ingredient Substances 0.000 claims description 7
• 230000037444 atrophy Effects 0.000 claims description 7
• 230000001684 chronic effect Effects 0.000 claims description 7
• 230000004064 dysfunction Effects 0.000 claims description 7
• 230000000069 prophylactic effect Effects 0.000 claims description 7
• 208000024827 Alzheimer disease Diseases 0.000 claims description 6
• 208000014644 Brain disease Diseases 0.000 claims description 6
• 208000031229 Cardiomyopathies Diseases 0.000 claims description 6
• 206010008748 Chorea Diseases 0.000 claims description 6
• 206010011878 Deafness Diseases 0.000 claims description 6
• 208000032274 Encephalopathy Diseases 0.000 claims description 6
• 208000021642 Muscular disease Diseases 0.000 claims description 6
• 208000002033 Myoclonus Diseases 0.000 claims description 6
• 206010028629 Myoglobinuria Diseases 0.000 claims description 6
• 201000009623 Myopathy Diseases 0.000 claims description 6
• 240000007817 Olea europaea Species 0.000 claims description 6
• 208000009415 Spinocerebellar Ataxias Diseases 0.000 claims description 6
• 208000010112 Spinocerebellar Degenerations Diseases 0.000 claims description 6
• 208000012601 choreatic disease Diseases 0.000 claims description 6
• 230000007850 degeneration Effects 0.000 claims description 6
• 206010012601 diabetes mellitus Diseases 0.000 claims description 6
• 230000010370 hearing loss Effects 0.000 claims description 6
• 231100000888 hearing loss Toxicity 0.000 claims description 6
• 208000016354 hearing loss disease Diseases 0.000 claims description 6
• 208000017169 kidney disease Diseases 0.000 claims description 6
• 230000003211 malignant effect Effects 0.000 claims description 6
• 208000035172 MERRF Diseases 0.000 claims description 5
• 206010042928 Syringomyelia Diseases 0.000 claims description 5
• 206010008118 cerebral infarction Diseases 0.000 claims description 5
• 208000026106 cerebrovascular disease Diseases 0.000 claims description 5
• 230000003412 degenerative effect Effects 0.000 claims description 5
• 230000002496 gastric effect Effects 0.000 claims description 5
• 230000001771 impaired effect Effects 0.000 claims description 5
• 230000003387 muscular Effects 0.000 claims description 5
• 230000007658 neurological function Effects 0.000 claims description 5
• 239000008194 pharmaceutical composition Substances 0.000 claims description 5
• 125000003386 piperidinyl group Chemical group 0.000 claims description 5
• 230000003252 repetitive effect Effects 0.000 claims description 5
• 208000006011 Stroke Diseases 0.000 claims description 4
• 229910052799 carbon Inorganic materials 0.000 claims description 4
• 239000003937 drug carrier Substances 0.000 claims description 4
• 230000002285 radioactive effect Effects 0.000 claims description 4
• 102100032533 ADP/ATP translocase 1 Human genes 0.000 claims description 3
• 208000009304 Acute Kidney Injury Diseases 0.000 claims description 3
• 206010002027 Amyotrophy Diseases 0.000 claims description 3
• 208000009017 Athetosis Diseases 0.000 claims description 3
• 208000023275 Autoimmune disease Diseases 0.000 claims description 3
• 208000035183 Benign hereditary chorea Diseases 0.000 claims description 3
• 208000029402 Bulbospinal muscular atrophy Diseases 0.000 claims description 3
• 206010008025 Cerebellar ataxia Diseases 0.000 claims description 3
• 206010008111 Cerebral haemorrhage Diseases 0.000 claims description 3
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 3
• 241001112695 Clostridiales Species 0.000 claims description 3
• 208000026372 Congenital cystic kidney disease Diseases 0.000 claims description 3
• 102000012437 Copper-Transporting ATPases Human genes 0.000 claims description 3
• 102100025287 Cytochrome b Human genes 0.000 claims description 3
• 108010075028 Cytochromes b Proteins 0.000 claims description 3
• 201000003863 Dandy-Walker Syndrome Diseases 0.000 claims description 3
• 206010012289 Dementia Diseases 0.000 claims description 3
• 206010067889 Dementia with Lewy bodies Diseases 0.000 claims description 3
• 208000016192 Demyelinating disease Diseases 0.000 claims description 3
• 208000020401 Depressive disease Diseases 0.000 claims description 3
• 208000032131 Diabetic Neuropathies Diseases 0.000 claims description 3
• 208000002603 Dopa-responsive dystonia Diseases 0.000 claims description 3
• 208000014094 Dystonic disease Diseases 0.000 claims description 3
• 206010059284 Epidermal necrosis Diseases 0.000 claims description 3
• 101000768061 Escherichia phage P1 Antirepressor protein 1 Proteins 0.000 claims description 3
• 208000024412 Friedreich ataxia Diseases 0.000 claims description 3
• 201000011240 Frontotemporal dementia Diseases 0.000 claims description 3
• 206010064571 Gene mutation Diseases 0.000 claims description 3
• 201000004311 Gilles de la Tourette syndrome Diseases 0.000 claims description 3
• 208000035895 Guillain-Barré syndrome Diseases 0.000 claims description 3
• 206010019280 Heart failures Diseases 0.000 claims description 3
• 206010019663 Hepatic failure Diseases 0.000 claims description 3
• 208000002972 Hepatolenticular Degeneration Diseases 0.000 claims description 3
• 208000032087 Hereditary Leber Optic Atrophy Diseases 0.000 claims description 3
• 101000796932 Homo sapiens ADP/ATP translocase 1 Proteins 0.000 claims description 3
• 101000804964 Homo sapiens DNA polymerase subunit gamma-1 Proteins 0.000 claims description 3
• 101000595929 Homo sapiens POLG alternative reading frame Proteins 0.000 claims description 3
• 208000023105 Huntington disease Diseases 0.000 claims description 3
• 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims description 3
• 206010061598 Immunodeficiency Diseases 0.000 claims description 3
• 208000029462 Immunodeficiency disease Diseases 0.000 claims description 3
• 201000003533 Leber congenital amaurosis Diseases 0.000 claims description 3
• 208000009829 Lewy Body Disease Diseases 0.000 claims description 3
• 208000035177 MELAS Diseases 0.000 claims description 3
• 208000002569 Machado-Joseph Disease Diseases 0.000 claims description 3
• 208000019695 Migraine disease Diseases 0.000 claims description 3
• 206010049567 Miller Fisher syndrome Diseases 0.000 claims description 3
• 108020005196 Mitochondrial DNA Proteins 0.000 claims description 3
• 208000014844 Mitochondrial neurogastrointestinal encephalomyopathy Diseases 0.000 claims description 3
• 206010031264 Osteonecrosis Diseases 0.000 claims description 3
• 102100035196 POLG alternative reading frame Human genes 0.000 claims description 3
• 206010056332 Panencephalitis Diseases 0.000 claims description 3
• 208000027089 Parkinsonian disease Diseases 0.000 claims description 3
• 206010034010 Parkinsonism Diseases 0.000 claims description 3
• 206010065657 Paroxysmal choreoathetosis Diseases 0.000 claims description 3
• 208000013234 Pearson syndrome Diseases 0.000 claims description 3
• 208000000609 Pick Disease of the Brain Diseases 0.000 claims description 3
• 206010036105 Polyneuropathy Diseases 0.000 claims description 3
• 201000009916 Postpartum depression Diseases 0.000 claims description 3
• 208000024777 Prion disease Diseases 0.000 claims description 3
• 208000033063 Progressive myoclonic epilepsy Diseases 0.000 claims description 3
• 208000010378 Pulmonary Embolism Diseases 0.000 claims description 3
• 206010037764 Radiation myelopathy Diseases 0.000 claims description 3
• 101100240886 Rattus norvegicus Nptx2 gene Proteins 0.000 claims description 3
• 208000001647 Renal Insufficiency Diseases 0.000 claims description 3
• 206010038422 Renal cortical necrosis Diseases 0.000 claims description 3
• 208000033626 Renal failure acute Diseases 0.000 claims description 3
• 208000017442 Retinal disease Diseases 0.000 claims description 3
• 206010038923 Retinopathy Diseases 0.000 claims description 3
• 208000006289 Rett Syndrome Diseases 0.000 claims description 3
• 208000034189 Sclerosis Diseases 0.000 claims description 3
• 208000027919 Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome Diseases 0.000 claims description 3
• 201000010001 Silicosis Diseases 0.000 claims description 3
• 201000010829 Spina bifida Diseases 0.000 claims description 3
• 208000006097 Spinal Dysraphism Diseases 0.000 claims description 3
• 206010042033 Stevens-Johnson syndrome Diseases 0.000 claims description 3
• 231100000168 Stevens-Johnson syndrome Toxicity 0.000 claims description 3
• 206010072148 Stiff-Person syndrome Diseases 0.000 claims description 3
• 206010043189 Telangiectasia Diseases 0.000 claims description 3
• 206010044074 Torticollis Diseases 0.000 claims description 3
• 208000000323 Tourette Syndrome Diseases 0.000 claims description 3
• 208000016620 Tourette disease Diseases 0.000 claims description 3
• 208000028552 Treatment-Resistant Depressive disease Diseases 0.000 claims description 3
• 208000018839 Wilson disease Diseases 0.000 claims description 3
• 208000002552 acute disseminated encephalomyelitis Diseases 0.000 claims description 3
• 201000011040 acute kidney failure Diseases 0.000 claims description 3
• 208000012998 acute renal failure Diseases 0.000 claims description 3
• 206010064930 age-related macular degeneration Diseases 0.000 claims description 3
• 229940126575 aminoglycoside Drugs 0.000 claims description 3
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 3
• 208000007502 anemia Diseases 0.000 claims description 3
• 208000010123 anthracosis Diseases 0.000 claims description 3
• 208000025748 atypical depressive disease Diseases 0.000 claims description 3
• 210000004227 basal ganglia Anatomy 0.000 claims description 3
• 201000009267 bronchiectasis Diseases 0.000 claims description 3
• 210000003591 cerebellar nuclei Anatomy 0.000 claims description 3
• 206010008129 cerebral palsy Diseases 0.000 claims description 3
• 238000002512 chemotherapy Methods 0.000 claims description 3
• 230000001054 cortical effect Effects 0.000 claims description 3
• 230000003247 decreasing effect Effects 0.000 claims description 3
• 230000002950 deficient Effects 0.000 claims description 3
• 230000003210 demyelinating effect Effects 0.000 claims description 3
• 208000024732 dysthymic disease Diseases 0.000 claims description 3
• 208000010118 dystonia Diseases 0.000 claims description 3
• 201000006517 essential tremor Diseases 0.000 claims description 3
• 208000007386 hepatic encephalopathy Diseases 0.000 claims description 3
• 201000003636 hereditary ataxia Diseases 0.000 claims description 3
• 208000008675 hereditary spastic paraplegia Diseases 0.000 claims description 3
• 230000007813 immunodeficiency Effects 0.000 claims description 3
• 230000002757 inflammatory effect Effects 0.000 claims description 3
• 208000018197 inherited torticollis Diseases 0.000 claims description 3
• 208000036971 interstitial lung disease 2 Diseases 0.000 claims description 3
• GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical group C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 claims description 3
• 208000005430 kidney cortex necrosis Diseases 0.000 claims description 3
• 201000006370 kidney failure Diseases 0.000 claims description 3
• 208000007903 liver failure Diseases 0.000 claims description 3
• 231100000835 liver failure Toxicity 0.000 claims description 3
• 208000002780 macular degeneration Diseases 0.000 claims description 3
• 208000024714 major depressive disease Diseases 0.000 claims description 3
• 230000036244 malformation Effects 0.000 claims description 3
• 206010027599 migraine Diseases 0.000 claims description 3
• 230000002438 mitochondrial effect Effects 0.000 claims description 3
• 238000002156 mixing Methods 0.000 claims description 3
• 201000006417 multiple sclerosis Diseases 0.000 claims description 3
• 201000006938 muscular dystrophy Diseases 0.000 claims description 3
• 208000031225 myocardial ischemia Diseases 0.000 claims description 3
• 201000002648 nephronophthisis Diseases 0.000 claims description 3
• 201000009925 nephrosclerosis Diseases 0.000 claims description 3
• 201000001119 neuropathy Diseases 0.000 claims description 3
• 230000007823 neuropathy Effects 0.000 claims description 3
• 208000013667 paroxysmal dyskinesia Diseases 0.000 claims description 3
• 230000000737 periodic effect Effects 0.000 claims description 3
• 208000033808 peripheral neuropathy Diseases 0.000 claims description 3
• 208000000813 polyradiculoneuropathy Diseases 0.000 claims description 3
• 201000002241 progressive bulbar palsy Diseases 0.000 claims description 3
• 201000000980 schizophrenia Diseases 0.000 claims description 3
• 208000002916 sensory ataxic neuropathy, dysarthria, and ophthalmoparesis Diseases 0.000 claims description 3
• 230000001148 spastic effect Effects 0.000 claims description 3
• 208000020431 spinal cord injury Diseases 0.000 claims description 3
• 208000009056 telangiectasis Diseases 0.000 claims description 3
• 231100000331 toxic Toxicity 0.000 claims description 3
• 230000002588 toxic effect Effects 0.000 claims description 3
• 206010006542 Bulbar palsy Diseases 0.000 claims description 2
• 102000015782 Electron Transport Complex III Human genes 0.000 claims description 2
• 108010024882 Electron Transport Complex III Proteins 0.000 claims description 2
• 208000034800 Leukoencephalopathies Diseases 0.000 claims description 2
• 206010028851 Necrosis Diseases 0.000 claims description 2
• 208000035467 Pancreatic insufficiency Diseases 0.000 claims description 2
• 230000003376 axonal effect Effects 0.000 claims description 2
• 230000006735 deficit Effects 0.000 claims description 2
• 230000006806 disease prevention Effects 0.000 claims description 2
• 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
• 230000017074 necrotic cell death Effects 0.000 claims description 2
• 206010030875 ophthalmoplegia Diseases 0.000 claims description 2
• 208000001749 optic atrophy Diseases 0.000 claims description 2
• 208000030761 polycystic kidney disease Diseases 0.000 claims description 2
• 230000003449 preventive effect Effects 0.000 claims description 2
• 201000002212 progressive supranuclear palsy Diseases 0.000 claims description 2
• 230000001568 sexual effect Effects 0.000 claims description 2
• 208000009174 transverse myelitis Diseases 0.000 claims description 2
• 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 357
• 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 109
• 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 40
• 125000006620 amino-(C1-C6) alkyl group Chemical group 0.000 claims 13
• 125000006624 (C1-C6) alkoxycarbonylamino group Chemical group 0.000 claims 5
• 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 5
• 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 5
• 125000002768 hydroxyalkyl group Chemical class 0.000 claims 4
• GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 3
• 208000012672 seasonal affective disease Diseases 0.000 claims 1
• 150000001875 compounds Chemical class 0.000 description 241
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 220
• 238000002360 preparation method Methods 0.000 description 173
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 172
• 238000005160 1H NMR spectroscopy Methods 0.000 description 167
• 239000007858 starting material Substances 0.000 description 129
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 108
• 230000002829 reductive effect Effects 0.000 description 105
• 239000000203 mixture Substances 0.000 description 96
• 238000006243 chemical reaction Methods 0.000 description 92
• 239000000843 powder Substances 0.000 description 84
• 239000000243 solution Substances 0.000 description 82
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 74
• 125000004453 alkoxycarbonyl group Chemical group 0.000 description 73
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 66
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 58
• 238000002844 melting Methods 0.000 description 58
• 230000008018 melting Effects 0.000 description 58
• 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 54
• 125000004390 alkyl sulfonyl group Chemical group 0.000 description 48
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 45
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 41
• 125000004414 alkyl thio group Chemical group 0.000 description 40
• 239000012264 purified product Substances 0.000 description 39
• 238000010898 silica gel chromatography Methods 0.000 description 39
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 36
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 36
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 34
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
• 239000012044 organic layer Substances 0.000 description 33
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 30
• XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 29
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 27
• 235000019441 ethanol Nutrition 0.000 description 27
• 239000012442 inert solvent Substances 0.000 description 26
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 24
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 22
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 21
• 150000007514 bases Chemical class 0.000 description 21
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 20
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 20
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 20
• 239000011541 reaction mixture Substances 0.000 description 20
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
• KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 18
• VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 18
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 18
• 239000002904 solvent Substances 0.000 description 18
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 17
• OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 17
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 17
• XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 16
• 125000004432 carbon atom Chemical group C* 0.000 description 16
• 239000003054 catalyst Substances 0.000 description 16
• WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 15
• SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 15
• 229910052783 alkali metal Inorganic materials 0.000 description 15
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
• 238000010438 heat treatment Methods 0.000 description 14
• 238000010992 reflux Methods 0.000 description 14
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 13
• 125000005843 halogen group Chemical group 0.000 description 13
• 229910052763 palladium Inorganic materials 0.000 description 13
• 239000012312 sodium hydride Substances 0.000 description 13
• 229910000104 sodium hydride Inorganic materials 0.000 description 13
• ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 12
• 230000000694 effects Effects 0.000 description 12
• 150000007529 inorganic bases Chemical class 0.000 description 12
• 229910000027 potassium carbonate Inorganic materials 0.000 description 12
• 235000011181 potassium carbonates Nutrition 0.000 description 12
• GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 12
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 11
• 239000002253 acid Substances 0.000 description 11
• 238000000034 method Methods 0.000 description 11
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 10
• SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 10
• 238000001816 cooling Methods 0.000 description 10
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 10
• USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 10
• 238000001914 filtration Methods 0.000 description 10
• 150000007530 organic bases Chemical class 0.000 description 10
• 229910000029 sodium carbonate Inorganic materials 0.000 description 10
• MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 10
• 238000003756 stirring Methods 0.000 description 10
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 9
• 229960000583 acetic acid Drugs 0.000 description 9
• 239000012298 atmosphere Substances 0.000 description 9
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 9
• 229910000024 caesium carbonate Inorganic materials 0.000 description 9
• 229960003638 dopamine Drugs 0.000 description 9
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 9
• 229910052757 nitrogen Inorganic materials 0.000 description 9
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 9
• 239000002994 raw material Substances 0.000 description 9
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 9
• 235000017557 sodium bicarbonate Nutrition 0.000 description 9
• FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 9
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
• WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 8
• WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 8
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
• WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 8
• 229910000288 alkali metal carbonate Inorganic materials 0.000 description 8
• 150000008041 alkali metal carbonates Chemical class 0.000 description 8
• 150000001340 alkali metals Chemical class 0.000 description 8
• 229910052786 argon Inorganic materials 0.000 description 8
• 125000003118 aryl group Chemical group 0.000 description 8
• 239000004210 ether based solvent Substances 0.000 description 8
• 125000000623 heterocyclic group Chemical group 0.000 description 8
• GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 8
• 239000011261 inert gas Substances 0.000 description 8
• 239000002798 polar solvent Substances 0.000 description 8
• 239000003826 tablet Substances 0.000 description 8
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
• 238000002560 therapeutic procedure Methods 0.000 description 8
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 7
• 229920002472 Starch Polymers 0.000 description 7
• 235000011054 acetic acid Nutrition 0.000 description 7
• 239000005456 alcohol based solvent Substances 0.000 description 7
• 125000003342 alkenyl group Chemical group 0.000 description 7
• SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 7
• 150000002148 esters Chemical class 0.000 description 7
• XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 7
• 229910052808 lithium carbonate Inorganic materials 0.000 description 7
• 210000002569 neuron Anatomy 0.000 description 7
• 239000000825 pharmaceutical preparation Substances 0.000 description 7
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
• 239000008107 starch Substances 0.000 description 7
• 235000019698 starch Nutrition 0.000 description 7
• 208000024891 symptom Diseases 0.000 description 7
• 239000008096 xylene Substances 0.000 description 7
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
• 150000008044 alkali metal hydroxides Chemical class 0.000 description 6
• 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 6
• 150000001408 amides Chemical class 0.000 description 6
• 230000006870 function Effects 0.000 description 6
• 229960003975 potassium Drugs 0.000 description 6
• 229910052700 potassium Inorganic materials 0.000 description 6
• 239000011591 potassium Substances 0.000 description 6
• 229910000028 potassium bicarbonate Inorganic materials 0.000 description 6
• 235000015497 potassium bicarbonate Nutrition 0.000 description 6
• 239000011736 potassium bicarbonate Substances 0.000 description 6
• TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 6
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
• 229920006395 saturated elastomer Polymers 0.000 description 6
• 239000011734 sodium Substances 0.000 description 6
• 229910052708 sodium Inorganic materials 0.000 description 6
• VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
• IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 6
• CXNIUSPIQKWYAI-UHFFFAOYSA-N xantphos Chemical compound C=12OC3=C(P(C=4C=CC=CC=4)C=4C=CC=CC=4)C=CC=C3C(C)(C)C2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 CXNIUSPIQKWYAI-UHFFFAOYSA-N 0.000 description 6
• MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 description 5
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 5
• JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 5
• 239000007864 aqueous solution Substances 0.000 description 5
• 150000004945 aromatic hydrocarbons Chemical class 0.000 description 5
• HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 description 5
• 238000001035 drying Methods 0.000 description 5
• 239000000706 filtrate Substances 0.000 description 5
• 239000008103 glucose Substances 0.000 description 5
• 239000003446 ligand Substances 0.000 description 5
• PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 5
• 239000012299 nitrogen atmosphere Substances 0.000 description 5
• 239000003921 oil Substances 0.000 description 5
• 235000019198 oils Nutrition 0.000 description 5
• NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 5
• 229910000105 potassium hydride Inorganic materials 0.000 description 5
• 229940086066 potassium hydrogencarbonate Drugs 0.000 description 5
• 239000000047 product Substances 0.000 description 5
• 235000019260 propionic acid Nutrition 0.000 description 5
• PMZDQRJGMBOQBF-UHFFFAOYSA-N quinolin-4-ol Chemical class C1=CC=C2C(O)=CC=NC2=C1 PMZDQRJGMBOQBF-UHFFFAOYSA-N 0.000 description 5
• 238000006722 reduction reaction Methods 0.000 description 5
• 239000000725 suspension Substances 0.000 description 5
• CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 4
• YZUPZGFPHUVJKC-UHFFFAOYSA-N 1-bromo-2-methoxyethane Chemical compound COCCBr YZUPZGFPHUVJKC-UHFFFAOYSA-N 0.000 description 4
• SAKDZEUVNMDGAI-UHFFFAOYSA-N 3-propoxynaphthalen-2-amine Chemical compound C1=CC=C2C=C(N)C(OCCC)=CC2=C1 SAKDZEUVNMDGAI-UHFFFAOYSA-N 0.000 description 4
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 4
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
• PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
• FZENGILVLUJGJX-UHFFFAOYSA-N acetaldehyde oxime Chemical compound CC=NO FZENGILVLUJGJX-UHFFFAOYSA-N 0.000 description 4
• 239000003377 acid catalyst Substances 0.000 description 4
• 230000009471 action Effects 0.000 description 4
• 229910000102 alkali metal hydride Inorganic materials 0.000 description 4
• 150000008046 alkali metal hydrides Chemical class 0.000 description 4
• 150000001412 amines Chemical class 0.000 description 4
• 239000002585 base Substances 0.000 description 4
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
• MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical group C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 4
• 239000000969 carrier Substances 0.000 description 4
• 239000000460 chlorine Substances 0.000 description 4
• 229910052802 copper Inorganic materials 0.000 description 4
• 239000010949 copper Substances 0.000 description 4
• 229930195712 glutamate Natural products 0.000 description 4
• 229910052740 iodine Inorganic materials 0.000 description 4
• 239000005453 ketone based solvent Substances 0.000 description 4
• 239000008101 lactose Substances 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• 229910052744 lithium Inorganic materials 0.000 description 4
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
• RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 4
• BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 4
• LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 4
• ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 4
• QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 4
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
• LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
• YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 4
• NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 3
• WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
• WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 3
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
• MMFKFURHBSCRPV-UHFFFAOYSA-N 2-iodo-5-propoxy-4h-benzo[f]quinolin-1-one Chemical compound N1C=C(I)C(=O)C2=C1C(OCCC)=CC1=CC=CC=C12 MMFKFURHBSCRPV-UHFFFAOYSA-N 0.000 description 3
• 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 3
• YINVHYKKFOMFJP-UHFFFAOYSA-N 3-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]propanoic acid Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCC(O)=O)C=C2C1=CC=C(OC)C=C1 YINVHYKKFOMFJP-UHFFFAOYSA-N 0.000 description 3
• 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 3
• DISHHUPUKRZKRY-UHFFFAOYSA-N 5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxy-1h-quinoline-2-carboxylic acid Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1NC(C(O)=O)=C2C1=CC=C(OC)C=C1 DISHHUPUKRZKRY-UHFFFAOYSA-N 0.000 description 3
• CPUOPWIKBFFBNE-UHFFFAOYSA-N 5-methyl-1-benzofuran-7-amine Chemical compound CC1=CC(N)=C2OC=CC2=C1 CPUOPWIKBFFBNE-UHFFFAOYSA-N 0.000 description 3
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
• 239000005995 Aluminium silicate Substances 0.000 description 3
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
• 108010010803 Gelatin Proteins 0.000 description 3
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
• 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 102100022353 Ribosyldihydronicotinamide dehydrogenase [quinone] Human genes 0.000 description 3
• 101710131813 Ribosyldihydronicotinamide dehydrogenase [quinone] Proteins 0.000 description 3
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
• 229920002125 Sokalan® Polymers 0.000 description 3
• DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
• 230000002378 acidificating effect Effects 0.000 description 3
• 150000007513 acids Chemical class 0.000 description 3
• 150000001298 alcohols Chemical class 0.000 description 3
• 150000004703 alkoxides Chemical class 0.000 description 3
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
• 235000012211 aluminium silicate Nutrition 0.000 description 3
• 239000003146 anticoagulant agent Substances 0.000 description 3
• 125000004429 atom Chemical group 0.000 description 3
• 239000011230 binding agent Substances 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 229910000019 calcium carbonate Inorganic materials 0.000 description 3
• 239000002775 capsule Substances 0.000 description 3
• 239000003638 chemical reducing agent Substances 0.000 description 3
• 229910052801 chlorine Inorganic materials 0.000 description 3
• 239000000812 cholinergic antagonist Substances 0.000 description 3
• 230000007012 clinical effect Effects 0.000 description 3
• 229910017052 cobalt Inorganic materials 0.000 description 3
• 239000010941 cobalt Substances 0.000 description 3
• GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 3
• 238000002648 combination therapy Methods 0.000 description 3
• 238000010511 deprotection reaction Methods 0.000 description 3
• ZWWWLCMDTZFSOO-UHFFFAOYSA-N diethoxyphosphorylformonitrile Chemical compound CCOP(=O)(C#N)OCC ZWWWLCMDTZFSOO-UHFFFAOYSA-N 0.000 description 3
• YEWZQCDRZRYAEB-UHFFFAOYSA-M ditert-butyl phosphate Chemical compound CC(C)(C)OP([O-])(=O)OC(C)(C)C YEWZQCDRZRYAEB-UHFFFAOYSA-M 0.000 description 3
• 239000003136 dopamine receptor stimulating agent Substances 0.000 description 3
• 239000000839 emulsion Substances 0.000 description 3
• 239000002532 enzyme inhibitor Substances 0.000 description 3
• 229910052731 fluorine Inorganic materials 0.000 description 3
• 239000008273 gelatin Substances 0.000 description 3
• 229920000159 gelatin Polymers 0.000 description 3
• 235000019322 gelatine Nutrition 0.000 description 3
• 235000011852 gelatine desserts Nutrition 0.000 description 3
• 150000008282 halocarbons Chemical class 0.000 description 3
• 239000007924 injection Substances 0.000 description 3
• 238000002347 injection Methods 0.000 description 3
• 239000002198 insoluble material Substances 0.000 description 3
• 239000011630 iodine Substances 0.000 description 3
• 150000002500 ions Chemical class 0.000 description 3
• NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
• 239000010410 layer Substances 0.000 description 3
• 230000007246 mechanism Effects 0.000 description 3
• 210000001259 mesencephalon Anatomy 0.000 description 3
• 150000007522 mineralic acids Chemical class 0.000 description 3
• 230000004065 mitochondrial dysfunction Effects 0.000 description 3
• ALHILVNKUXZSCC-UHFFFAOYSA-N n-(3-propoxynaphthalen-2-yl)acetamide Chemical compound C1=CC=C2C=C(NC(C)=O)C(OCCC)=CC2=C1 ALHILVNKUXZSCC-UHFFFAOYSA-N 0.000 description 3
• SNXGYJCXPKMLKQ-UHFFFAOYSA-N n-(5-methyl-1-benzofuran-7-yl)-1,1-diphenylmethanimine Chemical compound C=12OC=CC2=CC(C)=CC=1N=C(C=1C=CC=CC=1)C1=CC=CC=C1 SNXGYJCXPKMLKQ-UHFFFAOYSA-N 0.000 description 3
• 150000007524 organic acids Chemical class 0.000 description 3
• 150000002941 palladium compounds Chemical class 0.000 description 3
• 239000000546 pharmaceutical excipient Substances 0.000 description 3
• 239000006187 pill Substances 0.000 description 3
• 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 3
• 229910052697 platinum Inorganic materials 0.000 description 3
• 230000009467 reduction Effects 0.000 description 3
• 229920005989 resin Polymers 0.000 description 3
• 239000011347 resin Substances 0.000 description 3
• 235000009518 sodium iodide Nutrition 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 125000001424 substituent group Chemical group 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 239000000829 suppository Substances 0.000 description 3
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
• MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 2
• KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 2
• BMEMBBFDTYHTLH-UHFFFAOYSA-N 1-(2-methoxyethyl)piperazine Chemical compound COCCN1CCNCC1 BMEMBBFDTYHTLH-UHFFFAOYSA-N 0.000 description 2
• NSAKWSPDQRIISR-UHFFFAOYSA-N 1-(3-aminopropyl)-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCN)C=C2C1=CC=C(OC)C=C1 NSAKWSPDQRIISR-UHFFFAOYSA-N 0.000 description 2
• IEGQNITZGJGCTD-UHFFFAOYSA-N 1-(5-propoxy-2,3-dihydro-1-benzofuran-6-yl)ethanone Chemical compound C1=C(C(C)=O)C(OCCC)=CC2=C1OCC2 IEGQNITZGJGCTD-UHFFFAOYSA-N 0.000 description 2
• CQMJEZQEVXQEJB-UHFFFAOYSA-N 1-hydroxy-1,3-dioxobenziodoxole Chemical compound C1=CC=C2I(O)(=O)OC(=O)C2=C1 CQMJEZQEVXQEJB-UHFFFAOYSA-N 0.000 description 2
• 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 2
• QXEVFMAIGQPLEH-UHFFFAOYSA-N 2-(4-methoxyphenyl)-4-(3-morpholin-4-ylpropyl)-5-propoxy-8,9-dihydro-7h-cyclopenta[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCC=2C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCCN1CCOCC1 QXEVFMAIGQPLEH-UHFFFAOYSA-N 0.000 description 2
• BZXNFBXCCQVUEP-UHFFFAOYSA-N 2-(furan-3-yl)-5-propoxy-4h-benzo[f]quinolin-1-one Chemical compound CCCOC1=CC2=CC=CC=C2C(C2=O)=C1NC=C2C=1C=COC=1 BZXNFBXCCQVUEP-UHFFFAOYSA-N 0.000 description 2
• OYXYRQKCYUDLOL-UHFFFAOYSA-N 2-[3-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]propyl]isoindole-1,3-dione Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCN1C(C3=CC=CC=C3C1=O)=O)C=C2C1=CC=C(OC)C=C1 OYXYRQKCYUDLOL-UHFFFAOYSA-N 0.000 description 2
• DOJBEAIAFHPGDP-UHFFFAOYSA-N 2-[5-fluoro-3-(4-hydroxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]-n-(2-morpholin-4-ylethyl)acetamide Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(O)=CC=2)=C2)=O)=C1N2CC(=O)NCCN1CCOCC1 DOJBEAIAFHPGDP-UHFFFAOYSA-N 0.000 description 2
• SWWJBBYYPXYSNF-UHFFFAOYSA-N 2-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]-n-(2-morpholin-4-ylethyl)acetamide Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CC(=O)NCCN1CCOCC1 SWWJBBYYPXYSNF-UHFFFAOYSA-N 0.000 description 2
• OTVSTXNGFNIRIP-UHFFFAOYSA-N 2-[5-fluoro-3-[4-(2-hydroxyethoxy)phenyl]-4-oxo-8-propoxyquinolin-1-yl]acetic acid Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CC(O)=O)C=C2C1=CC=C(OCCO)C=C1 OTVSTXNGFNIRIP-UHFFFAOYSA-N 0.000 description 2
• BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical compound CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 2
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
• FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
• VMGHYYAGULXIIM-UHFFFAOYSA-N 3-[2-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]ethylsulfanyl]propanoic acid Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCSCCC(O)=O)C=C2C1=CC=C(OC)C=C1 VMGHYYAGULXIIM-UHFFFAOYSA-N 0.000 description 2
• MNMRRJUGHZZDFF-UHFFFAOYSA-N 3-[2-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]ethylsulfonyl]propanal Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCS(=O)(=O)CCC=O)C=C2C1=CC=C(OC)C=C1 MNMRRJUGHZZDFF-UHFFFAOYSA-N 0.000 description 2
• WZZQCWWNJXVDOJ-UHFFFAOYSA-N 3-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]propanal Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCC=O)C=C2C1=CC=C(OC)C=C1 WZZQCWWNJXVDOJ-UHFFFAOYSA-N 0.000 description 2
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
• NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
• KAQCGIQHINGUGV-UHFFFAOYSA-N 3-propoxy-5,6,7,8-tetrahydronaphthalen-2-amine Chemical compound C1CCCC2=C1C=C(OCCC)C(N)=C2 KAQCGIQHINGUGV-UHFFFAOYSA-N 0.000 description 2
• NHNVMXJUBRMWPT-UHFFFAOYSA-N 4-(3-chloropropyl)-2-(4-methoxyphenyl)-5-propoxy-8,9-dihydro-7h-cyclopenta[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCC=2C(C2=O)=C1N(CCCCl)C=C2C1=CC=C(OC)C=C1 NHNVMXJUBRMWPT-UHFFFAOYSA-N 0.000 description 2
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
• XSFLYUMYMLVQAX-UHFFFAOYSA-N 5-bromo-6-propoxy-2,3-dihydro-1h-indene Chemical compound C1=C(Br)C(OCCC)=CC2=C1CCC2 XSFLYUMYMLVQAX-UHFFFAOYSA-N 0.000 description 2
• SXDZQDZPVYKDCD-UHFFFAOYSA-N 5-fluoro-1-[2-(3-hydroxypropylsulfonyl)ethyl]-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCS(=O)(=O)CCCO)C=C2C1=CC=C(OC)C=C1 SXDZQDZPVYKDCD-UHFFFAOYSA-N 0.000 description 2
• GQNHDCOOAPIJLO-UHFFFAOYSA-N 5-fluoro-3-(4-methoxyphenyl)-8-propoxy-1h-quinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1NC=C2C1=CC=C(OC)C=C1 GQNHDCOOAPIJLO-UHFFFAOYSA-N 0.000 description 2
• MBIPSEYYKQUKLU-UHFFFAOYSA-N 5-fluoro-3-[4-(4-morpholin-4-ylpiperidine-1-carbonyl)phenyl]-8-propoxy-1h-quinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1NC=C2C(C=C1)=CC=C1C(=O)N(CC1)CCC1N1CCOCC1 MBIPSEYYKQUKLU-UHFFFAOYSA-N 0.000 description 2
• FMYMMVLLZYTUGU-UHFFFAOYSA-N 5-fluoro-8-(2-hydroxyethoxy)-3-(4-methoxyphenyl)-1h-quinolin-4-one Chemical compound C1=CC(OC)=CC=C1C1=CNC2=C(OCCO)C=CC(F)=C2C1=O FMYMMVLLZYTUGU-UHFFFAOYSA-N 0.000 description 2
• WALQPXMNTGSWDW-UHFFFAOYSA-N 5-methyl-2,3-dihydro-1-benzofuran-7-amine Chemical compound NC1=CC(C)=CC2=C1OCC2 WALQPXMNTGSWDW-UHFFFAOYSA-N 0.000 description 2
• SBHFTVCJDNXKGL-UHFFFAOYSA-N 5-propoxy-2,3-dihydro-1-benzofuran-6-amine Chemical compound C1=C(N)C(OCCC)=CC2=C1OCC2 SBHFTVCJDNXKGL-UHFFFAOYSA-N 0.000 description 2
• CAJWWBOLZVAWLC-UHFFFAOYSA-N 5-propoxy-4h-benzo[f]quinolin-1-one Chemical compound N1C=CC(=O)C2=C1C(OCCC)=CC1=CC=CC=C12 CAJWWBOLZVAWLC-UHFFFAOYSA-N 0.000 description 2
• XEYHQRLIRUOPJL-UHFFFAOYSA-N 9-(4-methoxyphenyl)-6-propoxy-2,3,4,7-tetrahydropyrano[2,3-f]quinolin-10-one Chemical compound CCCOC1=CC=2CCCOC=2C(C2=O)=C1NC=C2C1=CC=C(OC)C=C1 XEYHQRLIRUOPJL-UHFFFAOYSA-N 0.000 description 2
• IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
• 229920001817 Agar Polymers 0.000 description 2
• 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 2
• 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 2
• 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 2
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
• 208000027534 Emotional disease Diseases 0.000 description 2
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
• 101001018717 Homo sapiens Mitofusin-2 Proteins 0.000 description 2
• WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
• 229920001543 Laminarin Polymers 0.000 description 2
• 239000002841 Lewis acid Substances 0.000 description 2
• 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 2
• 102100033703 Mitofusin-2 Human genes 0.000 description 2
• SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
• 206010033799 Paralysis Diseases 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• 229920001214 Polysorbate 60 Polymers 0.000 description 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
• UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
• 229930006000 Sucrose Natural products 0.000 description 2
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
• 206010044565 Tremor Diseases 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• DSFVQIUBODXRLL-UHFFFAOYSA-N acetamide;dihydrochloride Chemical compound Cl.Cl.CC(N)=O DSFVQIUBODXRLL-UHFFFAOYSA-N 0.000 description 2
• 239000008272 agar Substances 0.000 description 2
• 235000010419 agar Nutrition 0.000 description 2
• 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
• 229940024606 amino acid Drugs 0.000 description 2
• 150000001413 amino acids Chemical class 0.000 description 2
• 235000019270 ammonium chloride Nutrition 0.000 description 2
• DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 2
• RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
• 230000006793 arrhythmia Effects 0.000 description 2
• 206010003119 arrhythmia Diseases 0.000 description 2
• 125000005279 aryl sulfonyloxy group Chemical group 0.000 description 2
• VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 2
• WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
• 238000010531 catalytic reduction reaction Methods 0.000 description 2
• 150000001768 cations Chemical class 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 239000000544 cholinesterase inhibitor Substances 0.000 description 2
• 229940110456 cocoa butter Drugs 0.000 description 2
• 235000019868 cocoa butter Nutrition 0.000 description 2
• 230000003920 cognitive function Effects 0.000 description 2
• 238000007796 conventional method Methods 0.000 description 2
• 235000014113 dietary fatty acids Nutrition 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• SXZIXHOMFPUIRK-UHFFFAOYSA-N diphenylmethanimine Chemical compound C=1C=CC=CC=1C(=N)C1=CC=CC=C1 SXZIXHOMFPUIRK-UHFFFAOYSA-N 0.000 description 2
• 239000007884 disintegrant Substances 0.000 description 2
• ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 description 2
• 238000002651 drug therapy Methods 0.000 description 2
• IHWSNRABFQWOJN-UHFFFAOYSA-N ethyl 2-[5-fluoro-3-[4-[2-(oxan-2-yloxy)ethoxy]phenyl]-4-oxo-8-propoxyquinolin-1-yl]acetate Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CC(=O)OCC)C=C2C(C=C1)=CC=C1OCCOC1CCCCO1 IHWSNRABFQWOJN-UHFFFAOYSA-N 0.000 description 2
• YLLRCCQYCGLDBC-UHFFFAOYSA-N ethyl 2-[9-(4-methoxyphenyl)-10-oxo-6-propoxy-3,4-dihydro-2h-pyrano[2,3-f]quinolin-7-yl]acetate Chemical compound CCCOC1=CC=2CCCOC=2C(C2=O)=C1N(CC(=O)OCC)C=C2C1=CC=C(OC)C=C1 YLLRCCQYCGLDBC-UHFFFAOYSA-N 0.000 description 2
• MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 2
• PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 2
• 238000000605 extraction Methods 0.000 description 2
• 229930195729 fatty acid Natural products 0.000 description 2
• 239000000194 fatty acid Substances 0.000 description 2
• 239000011737 fluorine Substances 0.000 description 2
• QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 2
• 235000019253 formic acid Nutrition 0.000 description 2
• ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 229940093915 gynecological organic acid Drugs 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• 239000005457 ice water Substances 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
• 229910052742 iron Inorganic materials 0.000 description 2
• 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 2
• DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 description 2
• 150000007517 lewis acids Chemical class 0.000 description 2
• 239000000314 lubricant Substances 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
• 239000012046 mixed solvent Substances 0.000 description 2
• 238000000465 moulding Methods 0.000 description 2
• GVLLPLLOSZNYMI-UHFFFAOYSA-N n-(3-hydroxynaphthalen-2-yl)acetamide Chemical compound C1=CC=C2C=C(O)C(NC(=O)C)=CC2=C1 GVLLPLLOSZNYMI-UHFFFAOYSA-N 0.000 description 2
• RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical compound NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 description 2
• PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 2
• 125000001624 naphthyl group Chemical group 0.000 description 2
• 210000005036 nerve Anatomy 0.000 description 2
• 210000000653 nervous system Anatomy 0.000 description 2
• 230000003961 neuronal insult Effects 0.000 description 2
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
• 235000005985 organic acids Nutrition 0.000 description 2
• NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
• 238000001050 pharmacotherapy Methods 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 229910000160 potassium phosphate Inorganic materials 0.000 description 2
• 235000011009 potassium phosphates Nutrition 0.000 description 2
• IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
• 239000002516 radical scavenger Substances 0.000 description 2
• 238000001953 recrystallisation Methods 0.000 description 2
• 230000008439 repair process Effects 0.000 description 2
• 230000001932 seasonal effect Effects 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 239000000741 silica gel Substances 0.000 description 2
• 229910002027 silica gel Inorganic materials 0.000 description 2
• RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
• 235000012239 silicon dioxide Nutrition 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
• 239000012453 solvate Substances 0.000 description 2
• 239000005720 sucrose Substances 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• MRZAJICIQJIOIC-UHFFFAOYSA-N tert-butyl 4-[[2-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]acetyl]amino]piperidine-1-carboxylate Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CC(=O)NC1CCN(C(=O)OC(C)(C)C)CC1 MRZAJICIQJIOIC-UHFFFAOYSA-N 0.000 description 2
• LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical compound CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 description 2
• 230000002537 thrombolytic effect Effects 0.000 description 2
• 238000003354 tissue distribution assay Methods 0.000 description 2
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
• YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
• BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 2
• VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
• LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
• UQFGRTLIQGZUAA-IKXQUJFKSA-N (2s)-2,6-diamino-n-[2-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]ethyl]hexanamide;dihydrochloride Chemical compound Cl.Cl.CCCOC1=CC=C(F)C(C2=O)=C1N(CCNC(=O)[C@@H](N)CCCCN)C=C2C1=CC=C(OC)C=C1 UQFGRTLIQGZUAA-IKXQUJFKSA-N 0.000 description 1
• NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
• FHOAKXBXYSJBGX-YFKPBYRVSA-N (2s)-3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@@H](CO)C(O)=O FHOAKXBXYSJBGX-YFKPBYRVSA-N 0.000 description 1
• JIRHAGAOHOYLNO-UHFFFAOYSA-N (3-cyclopentyloxy-4-methoxyphenyl)methanol Chemical compound COC1=CC=C(CO)C=C1OC1CCCC1 JIRHAGAOHOYLNO-UHFFFAOYSA-N 0.000 description 1
• MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
• DPEYHNFHDIXMNV-UHFFFAOYSA-N (9-amino-3-bicyclo[3.3.1]nonanyl)-(4-benzyl-5-methyl-1,4-diazepan-1-yl)methanone dihydrochloride Chemical compound Cl.Cl.CC1CCN(CCN1Cc1ccccc1)C(=O)C1CC2CCCC(C1)C2N DPEYHNFHDIXMNV-UHFFFAOYSA-N 0.000 description 1
• ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
• PCTZLSCYMRXUGW-UHFFFAOYSA-N 1,1,1,2,2-pentafluorobutane Chemical group [CH2]CC(F)(F)C(F)(F)F PCTZLSCYMRXUGW-UHFFFAOYSA-N 0.000 description 1
• FKTXDTWDCPTPHK-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical group FC(F)(F)[C](F)C(F)(F)F FKTXDTWDCPTPHK-UHFFFAOYSA-N 0.000 description 1
• 125000005919 1,2,2-trimethylpropyl group Chemical group 0.000 description 1
• SLLDDDJWIRFAGU-UHFFFAOYSA-N 1,2-dichlorocycloocta-1,5-diene Chemical compound ClC1=C(Cl)CCC=CCC1 SLLDDDJWIRFAGU-UHFFFAOYSA-N 0.000 description 1
• SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 1
• APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
• XXPCVOIFOVRHDY-UHFFFAOYSA-N 1-(2-aminoethyl)-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCN)C=C2C1=CC=C(OC)C=C1 XXPCVOIFOVRHDY-UHFFFAOYSA-N 0.000 description 1
• PJLVUKNRVNFLHY-UHFFFAOYSA-N 1-(2-bromoethyl)-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCBr)C=C2C1=CC=C(OC)C=C1 PJLVUKNRVNFLHY-UHFFFAOYSA-N 0.000 description 1
• JKLQHRRGLZYBFY-UHFFFAOYSA-N 1-(2-chloroethyl)-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCl)C=C2C1=CC=C(OC)C=C1 JKLQHRRGLZYBFY-UHFFFAOYSA-N 0.000 description 1
• DMLWECGRMPYZON-UHFFFAOYSA-N 1-(2-chloroethyl)-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one;methyl 3-[2-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]ethylsulfanyl]propanoate Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCl)C=C2C1=CC=C(OC)C=C1.CCCOC1=CC=C(F)C(C2=O)=C1N(CCSCCC(=O)OC)C=C2C1=CC=C(OC)C=C1 DMLWECGRMPYZON-UHFFFAOYSA-N 0.000 description 1
• HVFJAFQKEUJMLZ-UHFFFAOYSA-N 1-(3-bromopropyl)-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCBr)C=C2C1=CC=C(OC)C=C1 HVFJAFQKEUJMLZ-UHFFFAOYSA-N 0.000 description 1
• VURSEXUTRRHYBY-UHFFFAOYSA-N 1-(3-chloropropyl)-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCCl)C=C2C1=CC=C(OC)C=C1 VURSEXUTRRHYBY-UHFFFAOYSA-N 0.000 description 1
• VPBDWTCOCFMAHO-UHFFFAOYSA-N 1-(4-aminobutyl)-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCCN)C=C2C1=CC=C(OC)C=C1 VPBDWTCOCFMAHO-UHFFFAOYSA-N 0.000 description 1
• SLUMYODFWDIQIG-UHFFFAOYSA-N 1-(4-bromobutyl)-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCCBr)C=C2C1=CC=C(OC)C=C1 SLUMYODFWDIQIG-UHFFFAOYSA-N 0.000 description 1
• GYEWZRASCFDNQU-UHFFFAOYSA-N 1-(6-aminohexyl)-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCCCCN)C=C2C1=CC=C(OC)C=C1 GYEWZRASCFDNQU-UHFFFAOYSA-N 0.000 description 1
• DGEYDTBYLIBXIG-UHFFFAOYSA-N 1-(7-hydroxy-3,4-dihydro-2h-chromen-6-yl)ethanone Chemical compound C1CCOC2=C1C=C(C(=O)C)C(O)=C2 DGEYDTBYLIBXIG-UHFFFAOYSA-N 0.000 description 1
• ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
• PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
• OOSZCNKVJAVHJI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1CN1CCNCC1 OOSZCNKVJAVHJI-UHFFFAOYSA-N 0.000 description 1
• ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
• CPYYMJNAVXOEHM-UHFFFAOYSA-N 1-[2-[2-(dimethylamino)ethylsulfanyl]ethyl]-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one;hydrochloride Chemical compound Cl.CCCOC1=CC=C(F)C(C2=O)=C1N(CCSCCN(C)C)C=C2C1=CC=C(OC)C=C1 CPYYMJNAVXOEHM-UHFFFAOYSA-N 0.000 description 1
• XZNHRSJJKNRDIZ-UHFFFAOYSA-N 1-[3-(4-ethylpiperazin-1-yl)propyl]-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCCN1CCN(CC)CC1 XZNHRSJJKNRDIZ-UHFFFAOYSA-N 0.000 description 1
• UJOOBJHLSRTJBB-UHFFFAOYSA-N 1-[3-(diethylamino)propyl]-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCN(CC)CC)C=C2C1=CC=C(OC)C=C1 UJOOBJHLSRTJBB-UHFFFAOYSA-N 0.000 description 1
• SEULBGWFUHUBHW-UHFFFAOYSA-N 1-but-3-enyl-5-fluoro-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCC=C)C=C2C1=CC=C(OC)C=C1 SEULBGWFUHUBHW-UHFFFAOYSA-N 0.000 description 1
• 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
• 125000006039 1-hexenyl group Chemical group 0.000 description 1
• 125000006019 1-methyl-1-propenyl group Chemical group 0.000 description 1
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
• 125000006023 1-pentenyl group Chemical group 0.000 description 1
• 125000006017 1-propenyl group Chemical group 0.000 description 1
• 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
• OTTXCOAOKOEENK-UHFFFAOYSA-N 2,2-difluoroethenone Chemical group FC(F)=C=O OTTXCOAOKOEENK-UHFFFAOYSA-N 0.000 description 1
• SGCDSPVYLKXRHJ-UHFFFAOYSA-N 2,2-dimethyl-5-[[(3-propoxynaphthalen-2-yl)amino]methylidene]-1,3-dioxane-4,6-dione Chemical compound CCCOC1=CC2=CC=CC=C2C=C1NC=C1C(=O)OC(C)(C)OC1=O SGCDSPVYLKXRHJ-UHFFFAOYSA-N 0.000 description 1
• VPEPBQAFUWPVOG-UHFFFAOYSA-N 2,2-dimethyl-5-[[(3-propoxynaphthalen-2-yl)amino]methylidene]-1,3-dioxane-4,6-dione 5-propoxy-4H-benzo[f]quinolin-1-one Chemical compound CC1(OC(C(C(O1)=O)=CNC1=CC2=CC=CC=C2C=C1OCCC)=O)C.C(CC)OC1=CC2=C(C=3C(C=CNC13)=O)C=CC=C2 VPEPBQAFUWPVOG-UHFFFAOYSA-N 0.000 description 1
• VKJCJJYNVIYVQR-UHFFFAOYSA-N 2-(3-bromopropyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCCBr)C(=O)C2=C1 VKJCJJYNVIYVQR-UHFFFAOYSA-N 0.000 description 1
• FZESDOLHCCMGRA-UHFFFAOYSA-N 2-(4-methoxyphenyl)-3-methyl-5-propoxy-4,7,8,9-tetrahydrocyclopenta[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCC=2C(C2=O)=C1NC(C)=C2C1=CC=C(OC)C=C1 FZESDOLHCCMGRA-UHFFFAOYSA-N 0.000 description 1
• ZWGYNNQCKRFWGL-UHFFFAOYSA-N 2-(4-methoxyphenyl)-3-methyl-5-propoxy-7,8,9,10-tetrahydro-4h-benzo[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCCC=2C(C2=O)=C1NC(C)=C2C1=CC=C(OC)C=C1 ZWGYNNQCKRFWGL-UHFFFAOYSA-N 0.000 description 1
• FBLJWEACMGMBNX-UHFFFAOYSA-N 2-(4-methoxyphenyl)-4-(3-piperidin-1-ylpropyl)-5-propoxy-8,9-dihydro-7h-cyclopenta[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCC=2C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCCN1CCCCC1 FBLJWEACMGMBNX-UHFFFAOYSA-N 0.000 description 1
• XRMWHKJEBIQOSM-UHFFFAOYSA-N 2-(4-methoxyphenyl)-5-propoxy-4,7,8,9-tetrahydrocyclopenta[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCC=2C(C2=O)=C1NC=C2C1=CC=C(OC)C=C1 XRMWHKJEBIQOSM-UHFFFAOYSA-N 0.000 description 1
• CSPHETYSKABDHU-UHFFFAOYSA-N 2-(4-methoxyphenyl)-5-propoxy-4,7,9,10-tetrahydro-4,7-phenanthroline-1,8-dione Chemical compound CCCOC1=CC=2NC(=O)CCC=2C(C2=O)=C1NC=C2C1=CC=C(OC)C=C1 CSPHETYSKABDHU-UHFFFAOYSA-N 0.000 description 1
• VBCYUXHHKHQRAG-UHFFFAOYSA-N 2-(4-methoxyphenyl)-5-propoxy-4h-benzo[f]quinolin-1-one Chemical compound CCCOC1=CC2=CC=CC=C2C(C2=O)=C1NC=C2C1=CC=C(OC)C=C1 VBCYUXHHKHQRAG-UHFFFAOYSA-N 0.000 description 1
• DBWLXKCNRHIYHF-UHFFFAOYSA-N 2-(4-methoxyphenyl)-7-methyl-5-propoxy-9,10-dihydro-4h-4,7-phenanthroline-1,8-dione Chemical compound CCCOC1=CC=2N(C)C(=O)CCC=2C(C2=O)=C1NC=C2C1=CC=C(OC)C=C1 DBWLXKCNRHIYHF-UHFFFAOYSA-N 0.000 description 1
• QHTUMQYGZQYEOZ-UHFFFAOYSA-N 2-(4-methylpiperazin-1-yl)ethanol Chemical compound CN1CCN(CCO)CC1 QHTUMQYGZQYEOZ-UHFFFAOYSA-N 0.000 description 1
• RYYQKYQPXRFSNW-UHFFFAOYSA-N 2-(furan-3-yl)-4-methyl-5-propoxy-3H-benzo[f]quinoline Chemical compound O1C=C(C=C1)C=1CN(C=2C(=CC3=C(C2C1)C=CC=C3)OCCC)C RYYQKYQPXRFSNW-UHFFFAOYSA-N 0.000 description 1
• KUVGNXIDGQKQGX-UHFFFAOYSA-N 2-(furan-3-yl)-4-methyl-5-propoxybenzo[f]quinolin-1-one Chemical compound CCCOC1=CC2=CC=CC=C2C(C2=O)=C1N(C)C=C2C=1C=COC=1 KUVGNXIDGQKQGX-UHFFFAOYSA-N 0.000 description 1
• LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
• MSGSLZIAJXYTSU-UHFFFAOYSA-N 2-[2-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]ethyl]isoindole-1,3-dione Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCN1C(C3=CC=CC=C3C1=O)=O)C=C2C1=CC=C(OC)C=C1 MSGSLZIAJXYTSU-UHFFFAOYSA-N 0.000 description 1
• FGSBQLSTFDMIOL-UHFFFAOYSA-N 2-[4-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]butyl]isoindole-1,3-dione Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCCN1C(C3=CC=CC=C3C1=O)=O)C=C2C1=CC=C(OC)C=C1 FGSBQLSTFDMIOL-UHFFFAOYSA-N 0.000 description 1
• GZZDMNZSVPEWSH-UHFFFAOYSA-N 2-[5-fluoro-3-(4-hydroxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]acetic acid Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CC(O)=O)C=C2C1=CC=C(O)C=C1 GZZDMNZSVPEWSH-UHFFFAOYSA-N 0.000 description 1
• XDKCQXTZIBQENT-UHFFFAOYSA-N 2-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]-n-methyl-n-(2-morpholin-4-ylethyl)acetamide Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CC(=O)N(C)CCN1CCOCC1 XDKCQXTZIBQENT-UHFFFAOYSA-N 0.000 description 1
• AHDKNURALOOGAD-UHFFFAOYSA-N 2-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]-n-piperidin-4-ylacetamide Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CC(=O)NC1CCNCC1 AHDKNURALOOGAD-UHFFFAOYSA-N 0.000 description 1
• QXPCGZGYRTVDAT-UHFFFAOYSA-N 2-[6-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]hexyl]isoindole-1,3-dione Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCCCCN1C(C3=CC=CC=C3C1=O)=O)C=C2C1=CC=C(OC)C=C1 QXPCGZGYRTVDAT-UHFFFAOYSA-N 0.000 description 1
• KEOQVLBQZATLML-UHFFFAOYSA-N 2-[8-(4-methoxyphenyl)-9-oxo-5-propoxy-2,3-dihydrofuro[2,3-f]quinolin-6-yl]acetic acid Chemical compound CCCOC1=CC=2CCOC=2C(C2=O)=C1N(CC(O)=O)C=C2C1=CC=C(OC)C=C1 KEOQVLBQZATLML-UHFFFAOYSA-N 0.000 description 1
• CREISVAHUYMXJA-UHFFFAOYSA-N 2-[9-(4-methoxyphenyl)-10-oxo-6-propoxy-2,3-dihydro-1h-pyrano[3,2-f]quinolin-7-yl]acetic acid Chemical compound CCCOC1=CC=2OCCCC=2C(C2=O)=C1N(CC(O)=O)C=C2C1=CC=C(OC)C=C1 CREISVAHUYMXJA-UHFFFAOYSA-N 0.000 description 1
• OOMAVRPCACKAOZ-UHFFFAOYSA-N 2-[9-(4-methoxyphenyl)-10-oxo-6-propoxy-3,4-dihydro-2h-pyrano[2,3-f]quinolin-7-yl]-n-(2-morpholin-4-ylethyl)acetamide Chemical compound CCCOC1=CC=2CCCOC=2C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CC(=O)NCCN1CCOCC1 OOMAVRPCACKAOZ-UHFFFAOYSA-N 0.000 description 1
• SALJDYRGSBNBDP-UHFFFAOYSA-N 2-[9-(4-methoxyphenyl)-10-oxo-6-propoxy-3,4-dihydro-2h-pyrano[2,3-f]quinolin-7-yl]acetic acid Chemical compound CCCOC1=CC=2CCCOC=2C(C2=O)=C1N(CC(O)=O)C=C2C1=CC=C(OC)C=C1 SALJDYRGSBNBDP-UHFFFAOYSA-N 0.000 description 1
• VKIGRHQCIIQUAR-UHFFFAOYSA-N 2-[9-(4-methoxyphenyl)-10-oxo-6-propoxy-3,7-phenanthrolin-7-yl]acetic acid Chemical compound CCCOC1=CC2=CN=CC=C2C(C2=O)=C1N(CC(O)=O)C=C2C1=CC=C(OC)C=C1 VKIGRHQCIIQUAR-UHFFFAOYSA-N 0.000 description 1
• LGEXDLDNZLIZKD-UHFFFAOYSA-N 2-[[5-fluoro-3-(4-methoxyphenyl)-4-oxo-1h-quinolin-8-yl]oxy]acetic acid Chemical compound C1=CC(OC)=CC=C1C1=CNC2=C(OCC(O)=O)C=CC(F)=C2C1=O LGEXDLDNZLIZKD-UHFFFAOYSA-N 0.000 description 1
• 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
• 125000005999 2-bromoethyl group Chemical group 0.000 description 1
• 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
• QWFWIJKVSLDYEM-UHFFFAOYSA-N 2-chloro-n-[3-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]propyl]acetamide Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCNC(=O)CCl)C=C2C1=CC=C(OC)C=C1 QWFWIJKVSLDYEM-UHFFFAOYSA-N 0.000 description 1
• 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
• KKZUMAMOMRDVKA-UHFFFAOYSA-N 2-chloropropane Chemical group [CH2]C(C)Cl KKZUMAMOMRDVKA-UHFFFAOYSA-N 0.000 description 1
• 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
• 125000006040 2-hexenyl group Chemical group 0.000 description 1
• 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
• 125000006020 2-methyl-1-propenyl group Chemical group 0.000 description 1
• 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 1
• BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
• 125000006024 2-pentenyl group Chemical group 0.000 description 1
• AGBXYHCHUYARJY-UHFFFAOYSA-N 2-phenylethenesulfonic acid Chemical compound OS(=O)(=O)C=CC1=CC=CC=C1 AGBXYHCHUYARJY-UHFFFAOYSA-N 0.000 description 1
• HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
• BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
• WLAPKOVYJZYZHF-UHFFFAOYSA-N 3-[2-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]ethylsulfonyl]propanoic acid Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCS(=O)(=O)CCC(O)=O)C=C2C1=CC=C(OC)C=C1 WLAPKOVYJZYZHF-UHFFFAOYSA-N 0.000 description 1
• WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
• SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
• 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
• 125000006041 3-hexenyl group Chemical group 0.000 description 1
• DGYJJKSFBAKVPQ-UHFFFAOYSA-N 3-hydroxypropanamide;hydrochloride Chemical compound Cl.NC(=O)CCO DGYJJKSFBAKVPQ-UHFFFAOYSA-N 0.000 description 1
• UXZVSOAUOPUVOJ-UHFFFAOYSA-N 3-methyl-5-propoxy-2-thiophen-3-yl-4,7,8,9-tetrahydrocyclopenta[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCC=2C(C2=O)=C1NC(C)=C2C=1C=CSC=1 UXZVSOAUOPUVOJ-UHFFFAOYSA-N 0.000 description 1
• IRCXJZWKADEVAX-UHFFFAOYSA-N 3-methyl-5-propoxy-2-thiophen-3-yl-4h-benzo[f]quinolin-1-one Chemical compound CCCOC1=CC2=CC=CC=C2C(C2=O)=C1NC(C)=C2C=1C=CSC=1 IRCXJZWKADEVAX-UHFFFAOYSA-N 0.000 description 1
• 125000005917 3-methylpentyl group Chemical group 0.000 description 1
• NBJHDLKSWUDGJG-UHFFFAOYSA-N 4-(2-chloroethyl)morpholin-4-ium;chloride Chemical compound Cl.ClCCN1CCOCC1 NBJHDLKSWUDGJG-UHFFFAOYSA-N 0.000 description 1
• YQDMJVVNZBMJGP-UHFFFAOYSA-N 4-(3-chloropropyl)-5-propoxy-2-thiophen-3-yl-8,9-dihydro-7h-cyclopenta[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCC=2C(C2=O)=C1N(CCCCl)C=C2C=1C=CSC=1 YQDMJVVNZBMJGP-UHFFFAOYSA-N 0.000 description 1
• GMURWMLTEVZCAL-UHFFFAOYSA-N 4-(3-morpholin-4-ylpropyl)-5-propoxy-2-thiophen-3-yl-8,9-dihydro-7h-cyclopenta[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCC=2C(C(C(C2=CSC=C2)=C2)=O)=C1N2CCCN1CCOCC1 GMURWMLTEVZCAL-UHFFFAOYSA-N 0.000 description 1
• RYWAAYYDHJXRBB-UHFFFAOYSA-N 4-(5-fluoro-4-oxo-8-propoxy-1h-quinolin-3-yl)benzaldehyde Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1NC=C2C1=CC=C(C=O)C=C1 RYWAAYYDHJXRBB-UHFFFAOYSA-N 0.000 description 1
• URHFHSJYXMNUHW-UHFFFAOYSA-N 4-[4-(5-fluoro-4-oxo-8-propoxy-1h-quinolin-3-yl)phenoxy]butanoic acid Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1NC=C2C1=CC=C(OCCCC(O)=O)C=C1 URHFHSJYXMNUHW-UHFFFAOYSA-N 0.000 description 1
• YILBQOHXJDGWED-UHFFFAOYSA-N 4-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]butanoic acid Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCC(O)=O)C=C2C1=CC=C(OC)C=C1 YILBQOHXJDGWED-UHFFFAOYSA-N 0.000 description 1
• YSKJSURYJMELRS-UHFFFAOYSA-N 4-[[5-fluoro-3-(4-methoxyphenyl)-4-oxo-1h-quinolin-8-yl]oxy]butanoic acid Chemical compound C1=CC(OC)=CC=C1C1=CNC2=C(OCCCC(O)=O)C=CC(F)=C2C1=O YSKJSURYJMELRS-UHFFFAOYSA-N 0.000 description 1
• KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
• 125000006042 4-hexenyl group Chemical group 0.000 description 1
• 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
• 150000004331 4-hydroxyquinolines Chemical class 0.000 description 1
• 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
• QUNCJKIEXITUDR-UHFFFAOYSA-N 4-methyl-5-propoxy-2-thiophen-2-yl-8,9-dihydro-7h-cyclopenta[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCC=2C(C2=O)=C1N(C)C=C2C1=CC=CS1 QUNCJKIEXITUDR-UHFFFAOYSA-N 0.000 description 1
• XIDHKPHPXDKNHO-UHFFFAOYSA-N 4-methyl-5-propoxy-2-thiophen-2-ylbenzo[f]quinolin-1-one Chemical compound CCCOC1=CC2=CC=CC=C2C(C2=O)=C1N(C)C=C2C1=CC=CS1 XIDHKPHPXDKNHO-UHFFFAOYSA-N 0.000 description 1
• PRMPVVWMHQPRBL-UHFFFAOYSA-N 4-methyl-5-propoxy-2-thiophen-3-yl-8,9-dihydro-7h-cyclopenta[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCC=2C(C2=O)=C1N(C)C=C2C=1C=CSC=1 PRMPVVWMHQPRBL-UHFFFAOYSA-N 0.000 description 1
• MKWFFYOPNTVNAU-UHFFFAOYSA-N 4-methyl-5-propoxy-2-thiophen-3-ylbenzo[f]quinolin-1-one Chemical compound CCCOC1=CC2=CC=CC=C2C(C2=O)=C1N(C)C=C2C=1C=CSC=1 MKWFFYOPNTVNAU-UHFFFAOYSA-N 0.000 description 1
• IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
• PEBFWEOYJJHRBX-UHFFFAOYSA-N 5-fluoro-1-[2-(3-hydroxypropylsulfanyl)ethyl]-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCSCCCO)C=C2C1=CC=C(OC)C=C1 PEBFWEOYJJHRBX-UHFFFAOYSA-N 0.000 description 1
• CDYLJKZIPIFUTR-UHFFFAOYSA-N 5-fluoro-1-[3-(3-hydroxyazetidin-1-yl)propyl]-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one;hydrochloride Chemical compound Cl.CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCCN1CC(O)C1 CDYLJKZIPIFUTR-UHFFFAOYSA-N 0.000 description 1
• DNNWGCXGTKCXLH-UHFFFAOYSA-N 5-fluoro-1-[3-[4-(2-methoxyethyl)piperazin-1-yl]propyl]-3-(4-methoxyphenyl)-8-propoxyquinolin-4-one;dihydrochloride Chemical compound Cl.Cl.CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCCN1CCN(CCOC)CC1 DNNWGCXGTKCXLH-UHFFFAOYSA-N 0.000 description 1
• HFLRDYMQYCOTOX-UHFFFAOYSA-N 5-fluoro-3-(4-methoxyphenyl)-1-(2-morpholin-4-ylethyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCN1CCOCC1 HFLRDYMQYCOTOX-UHFFFAOYSA-N 0.000 description 1
• RJVFULJGKKFLAN-UHFFFAOYSA-N 5-fluoro-3-(4-methoxyphenyl)-1-(3-morpholin-4-ylpropyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCCN1CCOCC1 RJVFULJGKKFLAN-UHFFFAOYSA-N 0.000 description 1
• XUQCNDOPAQZHJY-UHFFFAOYSA-N 5-fluoro-3-(4-methoxyphenyl)-1-(3-piperidin-1-ylpropyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCCN1CCCCC1 XUQCNDOPAQZHJY-UHFFFAOYSA-N 0.000 description 1
• PIVBREXVMGMBQZ-UHFFFAOYSA-N 5-fluoro-3-(4-methoxyphenyl)-1-(4-morpholin-4-ylbutyl)-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCCCN1CCOCC1 PIVBREXVMGMBQZ-UHFFFAOYSA-N 0.000 description 1
• QFKKJLRIQBPPOK-UHFFFAOYSA-N 5-fluoro-3-(4-methoxyphenyl)-1-[2-[3-(4-methylpiperazin-1-yl)propylsulfonyl]ethyl]-8-propoxyquinolin-4-one;dihydrochloride Chemical compound Cl.Cl.CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCS(=O)(=O)CCCN1CCN(C)CC1 QFKKJLRIQBPPOK-UHFFFAOYSA-N 0.000 description 1
• FYORQYGWONJWNU-UHFFFAOYSA-N 5-fluoro-3-(4-methoxyphenyl)-1-[3-(4-methylpiperazin-1-yl)propyl]-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCCN1CCN(C)CC1 FYORQYGWONJWNU-UHFFFAOYSA-N 0.000 description 1
• UQPUBOZIZBXPIR-UHFFFAOYSA-N 5-fluoro-3-(4-methoxyphenyl)-1-[3-(4-morpholin-4-ylpiperidin-1-yl)propyl]-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCCN(CC1)CCC1N1CCOCC1 UQPUBOZIZBXPIR-UHFFFAOYSA-N 0.000 description 1
• RZPYTRTWTKHIJB-UHFFFAOYSA-N 5-fluoro-3-(4-methoxyphenyl)-1-[4-(4-methylpiperazin-1-yl)butyl]-8-propoxyquinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCCCN1CCN(C)CC1 RZPYTRTWTKHIJB-UHFFFAOYSA-N 0.000 description 1
• IOARDZYERZZIJY-UHFFFAOYSA-N 5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxy-1h-quinoline-2-carbaldehyde Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1NC(C=O)=C2C1=CC=C(OC)C=C1 IOARDZYERZZIJY-UHFFFAOYSA-N 0.000 description 1
• QXTAPZWPKUQZOI-UHFFFAOYSA-N 5-fluoro-3-(4-methoxyphenyl)-8-(2-phenylmethoxyethoxy)-1h-quinolin-4-one Chemical compound C1=CC(OC)=CC=C1C(C(C1=C(F)C=C2)=O)=CNC1=C2OCCOCC1=CC=CC=C1 QXTAPZWPKUQZOI-UHFFFAOYSA-N 0.000 description 1
• DROIHRMVYGBUNY-UHFFFAOYSA-N 5-fluoro-3-(4-methoxyphenyl)-8-propoxy-1-[3-(4-pyridin-2-ylpiperazin-1-yl)propyl]quinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCCN(CC1)CCN1C1=CC=CC=N1 DROIHRMVYGBUNY-UHFFFAOYSA-N 0.000 description 1
• ISFRUSNTEROANP-UHFFFAOYSA-N 5-fluoro-3-[4-(2-hydroxyethoxy)phenyl]-8-propoxy-1h-quinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1NC=C2C1=CC=C(OCCO)C=C1 ISFRUSNTEROANP-UHFFFAOYSA-N 0.000 description 1
• UZVGPMYFSVMLJH-UHFFFAOYSA-N 5-fluoro-3-[4-(2-phenylmethoxyethoxy)phenyl]-8-propoxy-1h-quinolin-4-one Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1NC=C2C(C=C1)=CC=C1OCCOCC1=CC=CC=C1 UZVGPMYFSVMLJH-UHFFFAOYSA-N 0.000 description 1
• ZXCZXDPAULOIDI-UHFFFAOYSA-N 5-fluoro-n-(2-hydroxyethyl)-3-(4-methoxyphenyl)-4-oxo-8-propoxy-1h-quinoline-2-carboxamide Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1NC(C(=O)NCCO)=C2C1=CC=C(OC)C=C1 ZXCZXDPAULOIDI-UHFFFAOYSA-N 0.000 description 1
• 125000006043 5-hexenyl group Chemical group 0.000 description 1
• GTBOZHGBIXYPFC-UHFFFAOYSA-N 5-methoxy-1-methyl-3-thiophen-2-yl-1,10-phenanthrolin-4-one Chemical compound O=C1C=2C(OC)=CC3=CC=CN=C3C=2N(C)C=C1C1=CC=CS1 GTBOZHGBIXYPFC-UHFFFAOYSA-N 0.000 description 1
• PTFVVELPQWCWNF-UHFFFAOYSA-N 5-methoxy-3-(4-methoxyphenyl)-1h-1,10-phenanthrolin-4-one Chemical compound C1=CC(OC)=CC=C1C1=CNC2=C(N=CC=C3)C3=CC(OC)=C2C1=O PTFVVELPQWCWNF-UHFFFAOYSA-N 0.000 description 1
• ZCFFEXCGFZSEKT-UHFFFAOYSA-N 5-methoxy-3-thiophen-2-yl-1h-1,10-phenanthrolin-4-one Chemical compound O=C1C=2C(OC)=CC3=CC=CN=C3C=2NC=C1C1=CC=CS1 ZCFFEXCGFZSEKT-UHFFFAOYSA-N 0.000 description 1
• DPJSULLYOPFUKF-UHFFFAOYSA-N 5-methoxy-3-thiophen-3-yl-1h-1,10-phenanthrolin-4-one;hydrochloride Chemical compound Cl.O=C1C=2C(OC)=CC3=CC=CN=C3C=2NC=C1C=1C=CSC=1 DPJSULLYOPFUKF-UHFFFAOYSA-N 0.000 description 1
• PONAPUGCHOVAQT-UHFFFAOYSA-N 5-propoxy-2-thiophen-2-yl-4,7,8,9-tetrahydrocyclopenta[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCC=2C(C2=O)=C1NC=C2C1=CC=CS1 PONAPUGCHOVAQT-UHFFFAOYSA-N 0.000 description 1
• WIJLMYJMYBANRS-UHFFFAOYSA-N 5-propoxy-2-thiophen-2-yl-4h-benzo[f]quinolin-1-one Chemical compound CCCOC1=CC2=CC=CC=C2C(C2=O)=C1NC=C2C1=CC=CS1 WIJLMYJMYBANRS-UHFFFAOYSA-N 0.000 description 1
• KOASQRRAOQDPSN-UHFFFAOYSA-N 5-propoxy-2-thiophen-3-yl-4,7,8,9-tetrahydrocyclopenta[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCC=2C(C2=O)=C1NC=C2C=1C=CSC=1 KOASQRRAOQDPSN-UHFFFAOYSA-N 0.000 description 1
• DDEFHYUFLOGXOO-UHFFFAOYSA-N 5-propoxy-2-thiophen-3-yl-4h-benzo[f]quinolin-1-one Chemical compound CCCOC1=CC2=CC=CC=C2C(C2=O)=C1NC=C2C=1C=CSC=1 DDEFHYUFLOGXOO-UHFFFAOYSA-N 0.000 description 1
• FQKVKBNHJHEHCK-UHFFFAOYSA-N 5-propoxy-2-thiophen-3-yl-7,8,9,10-tetrahydro-4h-benzo[f]quinolin-1-one Chemical compound CCCOC1=CC=2CCCCC=2C(C2=O)=C1NC=C2C=1C=CSC=1 FQKVKBNHJHEHCK-UHFFFAOYSA-N 0.000 description 1
• KADFWQVFMZEZAN-UHFFFAOYSA-N 5-propoxy-8-thiophen-3-yl-3,6-dihydro-2h-furo[2,3-f]quinolin-9-one Chemical compound CCCOC1=CC=2CCOC=2C(C2=O)=C1NC=C2C=1C=CSC=1 KADFWQVFMZEZAN-UHFFFAOYSA-N 0.000 description 1
• KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
• FTJKRWLEDIXIGS-UHFFFAOYSA-N 6-propoxy-2,3-dihydro-1h-inden-5-amine Chemical compound C1=C(N)C(OCCC)=CC2=C1CCC2 FTJKRWLEDIXIGS-UHFFFAOYSA-N 0.000 description 1
• SAPOVWHDPWKVRI-UHFFFAOYSA-N 7-(4-methoxyphenyl)-5-methyl-3,9-dihydro-2h-furo[3,2-h]quinolin-6-one Chemical compound C1=CC(OC)=CC=C1C1=CNC2=C(OCC3)C3=CC(C)=C2C1=O SAPOVWHDPWKVRI-UHFFFAOYSA-N 0.000 description 1
• RMYVPONVXNWGLH-UHFFFAOYSA-N 7-(4-methoxyphenyl)-5-methyl-9h-furo[3,2-h]quinolin-6-one Chemical compound C1=CC(OC)=CC=C1C1=CNC2=C(OC=C3)C3=CC(C)=C2C1=O RMYVPONVXNWGLH-UHFFFAOYSA-N 0.000 description 1
• TZUMDTURHSPEAY-UHFFFAOYSA-N 7-bromo-5-methyl-1-benzofuran Chemical compound CC1=CC(Br)=C2OC=CC2=C1 TZUMDTURHSPEAY-UHFFFAOYSA-N 0.000 description 1
• CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
• OKQCTTUQQFPDRQ-UHFFFAOYSA-N 8-(4-methoxyphenyl)-6-(2-morpholin-4-ylethyl)-5-propoxy-2,3-dihydrofuro[2,3-f]quinolin-9-one Chemical compound CCCOC1=CC=2CCOC=2C(C(C(C=2C=CC(OC)=CC=2)=C2)=O)=C1N2CCN1CCOCC1 OKQCTTUQQFPDRQ-UHFFFAOYSA-N 0.000 description 1
• LVLFORPFAUKIRM-UHFFFAOYSA-N 8-(4-methoxyphenyl)-7-methyl-5-propoxy-3,6-dihydro-2h-furo[2,3-f]quinolin-9-one Chemical compound CCCOC1=CC=2CCOC=2C(C2=O)=C1NC(C)=C2C1=CC=C(OC)C=C1 LVLFORPFAUKIRM-UHFFFAOYSA-N 0.000 description 1
• SUUYVUXFGWAHFM-UHFFFAOYSA-N 9-(4-methoxyphenyl)-6-propoxy-1,2,3,7-tetrahydropyrano[3,2-f]quinolin-10-one Chemical compound CCCOC1=CC=2OCCCC=2C(C2=O)=C1NC=C2C1=CC=C(OC)C=C1 SUUYVUXFGWAHFM-UHFFFAOYSA-N 0.000 description 1
• XAVXIJRSUHXPOI-UHFFFAOYSA-N 9-(4-methoxyphenyl)-6-propoxy-7h-3,7-phenanthrolin-10-one Chemical compound CCCOC1=CC2=CN=CC=C2C(C2=O)=C1NC=C2C1=CC=C(OC)C=C1 XAVXIJRSUHXPOI-UHFFFAOYSA-N 0.000 description 1
• 244000215068 Acacia senegal Species 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 208000013824 Acidemia Diseases 0.000 description 1
• 208000010444 Acidosis Diseases 0.000 description 1
• 206010001497 Agitation Diseases 0.000 description 1
• 208000037259 Amyloid Plaque Diseases 0.000 description 1
• 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
• 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 229910015900 BF3 Inorganic materials 0.000 description 1
• LDZFYICMXWMEJD-UHFFFAOYSA-N BrC=1C=C2CCCC2=CC1OCCC.C(CC)OC1=C(C=C2CCCC2=C1)N Chemical compound BrC=1C=C2CCCC2=CC1OCCC.C(CC)OC1=C(C=C2CCCC2=C1)N LDZFYICMXWMEJD-UHFFFAOYSA-N 0.000 description 1
• 206010048962 Brain oedema Diseases 0.000 description 1
• XKAHDOSRXZXBDY-UHFFFAOYSA-N C(C)(=O)NC1=CC2=C(CCO2)C=C1OCCC.C(C)(=O)NC1=CC2=C(CCO2)C=C1OCCC Chemical compound C(C)(=O)NC1=CC2=C(CCO2)C=C1OCCC.C(C)(=O)NC1=CC2=C(CCO2)C=C1OCCC XKAHDOSRXZXBDY-UHFFFAOYSA-N 0.000 description 1
• SDODYVDDPSNPRG-FTBISJDPSA-N C(C)(C)(C)OC(N[C@@H](CO)C(NCCN1C=C(C(C2=C(C=CC(=C12)OCCC)F)=O)C1=CC=C(C=C1)OC)=O)=O.Cl Chemical compound C(C)(C)(C)OC(N[C@@H](CO)C(NCCN1C=C(C(C2=C(C=CC(=C12)OCCC)F)=O)C1=CC=C(C=C1)OC)=O)=O.Cl SDODYVDDPSNPRG-FTBISJDPSA-N 0.000 description 1
• OMONTYVBMKYDSR-UHFFFAOYSA-N C(C)OC(CN1C=C(C(C2=C(C=CC(=C12)OCCC)F)=O)C1=CC=C(C=C1)OC)=O.C(C)OC(CN1C=C(C(C2=C(C=CC(=C12)OCCC)F)=O)C1=CC=C(C=C1)O)=O Chemical compound C(C)OC(CN1C=C(C(C2=C(C=CC(=C12)OCCC)F)=O)C1=CC=C(C=C1)OC)=O.C(C)OC(CN1C=C(C(C2=C(C=CC(=C12)OCCC)F)=O)C1=CC=C(C=C1)O)=O OMONTYVBMKYDSR-UHFFFAOYSA-N 0.000 description 1
• ZGGRHCLYRWPZEI-UHFFFAOYSA-N C(CC)OC=1C(=CC2=C(CCO2)C1)C(C)=O.C(CC)OC=1C(=CC2=C(CCO2)C1)C(C)=NO Chemical compound C(CC)OC=1C(=CC2=C(CCO2)C1)C(C)=O.C(CC)OC=1C(=CC2=C(CCO2)C1)C(C)=NO ZGGRHCLYRWPZEI-UHFFFAOYSA-N 0.000 description 1
• USIIHFWDUYZNIR-UHFFFAOYSA-N C(CC)OC=1C(=CC2=CC=CC=C2C1)N.COC1=CC=C(C=C1)C1=C(NC=2C(=CC3=C(C2C1=O)C=CC=C3)OCCC)C Chemical compound C(CC)OC=1C(=CC2=CC=CC=C2C1)N.COC1=CC=C(C=C1)C1=C(NC=2C(=CC3=C(C2C1=O)C=CC=C3)OCCC)C USIIHFWDUYZNIR-UHFFFAOYSA-N 0.000 description 1
• JHYVSCITHAZTOV-UHFFFAOYSA-N C(CC)OC=1C(=CC=2CCCCC2C1)C(C)=NO.C(C)(=O)NC1=CC=2CCCCC2C=C1OCCC Chemical compound C(CC)OC=1C(=CC=2CCCCC2C1)C(C)=NO.C(C)(=O)NC1=CC=2CCCCC2C=C1OCCC JHYVSCITHAZTOV-UHFFFAOYSA-N 0.000 description 1
• PKILKZSGBFFPLW-UHFFFAOYSA-N C(CC)OC=1C(=CC=2CCCCC2C1)C(C)=O.C(CC)OC=1C(=CC=2CCCCC2C1)C(C)=NO Chemical compound C(CC)OC=1C(=CC=2CCCCC2C1)C(C)=O.C(CC)OC=1C(=CC=2CCCCC2C1)C(C)=NO PKILKZSGBFFPLW-UHFFFAOYSA-N 0.000 description 1
• JGLMVXWAHNTPRF-CMDGGOBGSA-N CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O Chemical compound CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O JGLMVXWAHNTPRF-CMDGGOBGSA-N 0.000 description 1
• ZWBFPBHABDQFFP-UHFFFAOYSA-N COC1=CC=C(C=C1)C1=CN(C2=C(C=C3CCCOC3=C2C1=O)OCCC)CC(=O)O.C(C)(=O)N Chemical compound COC1=CC=C(C=C1)C1=CN(C2=C(C=C3CCCOC3=C2C1=O)OCCC)CC(=O)O.C(C)(=O)N ZWBFPBHABDQFFP-UHFFFAOYSA-N 0.000 description 1
• SSJUXNNXZILUET-UHFFFAOYSA-N COC1=CC=C(C=C1)C1CCC=2C1=C1C(C=CNC1=C(C2)OCCC)=O Chemical compound COC1=CC=C(C=C1)C1CCC=2C1=C1C(C=CNC1=C(C2)OCCC)=O SSJUXNNXZILUET-UHFFFAOYSA-N 0.000 description 1
• 239000004215 Carbon black (E152) Substances 0.000 description 1
• OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 206010008088 Cerebral artery embolism Diseases 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
• 229910021555 Chromium Chloride Inorganic materials 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• RCHISIMKWBJKJK-UHFFFAOYSA-N Cl.Cl.N1=CCC(C=2C3=CC=CC=C3C=CC12)=O Chemical compound Cl.Cl.N1=CCC(C=2C3=CC=CC=C3C=CC12)=O RCHISIMKWBJKJK-UHFFFAOYSA-N 0.000 description 1
• 229940081615 DOPA decarboxylase inhibitor Drugs 0.000 description 1
• 206010012239 Delusion Diseases 0.000 description 1
• YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
• 206010061818 Disease progression Diseases 0.000 description 1
• 208000002251 Dissecting Aneurysm Diseases 0.000 description 1
• 208000012661 Dyskinesia Diseases 0.000 description 1
• CXEGJWMDYSHYEV-UHFFFAOYSA-N FC1=C2C(C(=C(NC2=C(C=C1)OCCC)C(=O)O)C1=CC=C(C=C1)OC)=O.ClCCNC(=O)C=1NC2=C(C=CC(=C2C(C1C1=CC=C(C=C1)OC)=O)F)OCCC Chemical compound FC1=C2C(C(=C(NC2=C(C=C1)OCCC)C(=O)O)C1=CC=C(C=C1)OC)=O.ClCCNC(=O)C=1NC2=C(C=CC(=C2C(C1C1=CC=C(C=C1)OC)=O)F)OCCC CXEGJWMDYSHYEV-UHFFFAOYSA-N 0.000 description 1
• 239000004606 Fillers/Extenders Substances 0.000 description 1
• BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
• 229940123457 Free radical scavenger Drugs 0.000 description 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
• DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
• 229920000084 Gum arabic Polymers 0.000 description 1
• 239000007821 HATU Substances 0.000 description 1
• 208000004547 Hallucinations Diseases 0.000 description 1
• 208000032843 Hemorrhage Diseases 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• 229930182821 L-proline Natural products 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• 208000004552 Lacunar Stroke Diseases 0.000 description 1
• 206010051078 Lacunar infarction Diseases 0.000 description 1
• 206010024612 Lipoma Diseases 0.000 description 1
• OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
• 239000004909 Moisturizer Substances 0.000 description 1
• 206010061296 Motor dysfunction Diseases 0.000 description 1
• 208000001089 Multiple system atrophy Diseases 0.000 description 1
• 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
• 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 1
• 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 1
• AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
• VZOFGOXOXSJSKT-UHFFFAOYSA-N NC=1C(=CC2=CC=CC=C2C1)O.C(C)(=O)NC1=CC2=CC=CC=C2C=C1O Chemical compound NC=1C(=CC2=CC=CC=C2C1)O.C(C)(=O)NC1=CC2=CC=CC=C2C=C1O VZOFGOXOXSJSKT-UHFFFAOYSA-N 0.000 description 1
• NNQQYWUJXKUQQR-UHFFFAOYSA-N NCCN1C=C(C(C2=C(C=CC(=C12)OCCC)F)=O)C1=CC=C(C=C1)OC.C(C)(C)(C)OC(N)=O Chemical compound NCCN1C=C(C(C2=C(C=CC(=C12)OCCC)F)=O)C1=CC=C(C=C1)OC.C(C)(C)(C)OC(N)=O NNQQYWUJXKUQQR-UHFFFAOYSA-N 0.000 description 1
• 229940099433 NMDA receptor antagonist Drugs 0.000 description 1
• 229910002651 NO3 Inorganic materials 0.000 description 1
• 206010028813 Nausea Diseases 0.000 description 1
• 206010060860 Neurological symptom Diseases 0.000 description 1
• NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
• IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
• 206010031127 Orthostatic hypotension Diseases 0.000 description 1
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 229910021605 Palladium(II) bromide Inorganic materials 0.000 description 1
• 101150003085 Pdcl gene Proteins 0.000 description 1
• 206010037180 Psychiatric symptoms Diseases 0.000 description 1
• 239000007868 Raney catalyst Substances 0.000 description 1
• 229910000564 Raney nickel Inorganic materials 0.000 description 1
• 206010071390 Resting tremor Diseases 0.000 description 1
• XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 description 1
• 229920001800 Shellac Polymers 0.000 description 1
• DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 244000299461 Theobroma cacao Species 0.000 description 1
• 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
• 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
• ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 1
• 206010047700 Vomiting Diseases 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
• YHTPZODAYZVQMN-UHFFFAOYSA-N [8-(4-methoxyphenyl)-9-oxo-5-propoxy-2,3-dihydrofuro[2,3-f]quinolin-6-yl]methyl dihydrogen phosphate Chemical compound CCCOC1=CC=2CCOC=2C(C2=O)=C1N(COP(O)(O)=O)C=C2C1=CC=C(OC)C=C1 YHTPZODAYZVQMN-UHFFFAOYSA-N 0.000 description 1
• MNYVDLVUTBGNCD-UHFFFAOYSA-N [9-(4-methoxyphenyl)-10-oxo-6-propoxy-2,3-dihydro-1h-pyrano[3,2-f]quinolin-7-yl]methyl dihydrogen phosphate Chemical compound CCCOC1=CC=2OCCCC=2C(C2=O)=C1N(COP(O)(O)=O)C=C2C1=CC=C(OC)C=C1 MNYVDLVUTBGNCD-UHFFFAOYSA-N 0.000 description 1
• VVXDIGVGDYNUDY-UHFFFAOYSA-N [9-(4-methoxyphenyl)-10-oxo-6-propoxy-3,4-dihydro-2h-pyrano[2,3-f]quinolin-7-yl]methyl dihydrogen phosphate Chemical compound CCCOC1=CC=2CCCOC=2C(C2=O)=C1N(COP(O)(O)=O)C=C2C1=CC=C(OC)C=C1 VVXDIGVGDYNUDY-UHFFFAOYSA-N 0.000 description 1
• IZCBPSVSKAMYOG-UHFFFAOYSA-L [Na+].[Na+].CCCOC1=C2N(COP([O-])([O-])=O)C=C(C(=O)C2=C2OCCC2=C1)C1=CC=C(OC)C=C1 Chemical compound [Na+].[Na+].CCCOC1=C2N(COP([O-])([O-])=O)C=C(C(=O)C2=C2OCCC2=C1)C1=CC=C(OC)C=C1 IZCBPSVSKAMYOG-UHFFFAOYSA-L 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 239000003655 absorption accelerator Substances 0.000 description 1
• 235000010489 acacia gum Nutrition 0.000 description 1
• 239000000205 acacia gum Substances 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
• RBYGDVHOECIAFC-UHFFFAOYSA-L acetonitrile;palladium(2+);dichloride Chemical compound [Cl-].[Cl-].[Pd+2].CC#N.CC#N RBYGDVHOECIAFC-UHFFFAOYSA-L 0.000 description 1
• WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
• 239000012346 acetyl chloride Substances 0.000 description 1
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
• AXJDEHNQPMZKOS-UHFFFAOYSA-N acetylazanium;chloride Chemical compound [Cl-].CC([NH3+])=O AXJDEHNQPMZKOS-UHFFFAOYSA-N 0.000 description 1
• 230000002164 acetylcholinergic effect Effects 0.000 description 1
• 239000003463 adsorbent Substances 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
• 150000003973 alkyl amines Chemical class 0.000 description 1
• 150000003863 ammonium salts Chemical class 0.000 description 1
• 230000002785 anti-thrombosis Effects 0.000 description 1
• 206010002895 aortic dissection Diseases 0.000 description 1
• 229940039856 aricept Drugs 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• AYJRCSIUFZENHW-UHFFFAOYSA-L barium carbonate Inorganic materials [Ba+2].[O-]C([O-])=O AYJRCSIUFZENHW-UHFFFAOYSA-L 0.000 description 1
• TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Inorganic materials [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 1
• 239000000440 bentonite Substances 0.000 description 1
• 229910000278 bentonite Inorganic materials 0.000 description 1
• SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
• WXNOJTUTEXAZLD-UHFFFAOYSA-L benzonitrile;dichloropalladium Chemical compound Cl[Pd]Cl.N#CC1=CC=CC=C1.N#CC1=CC=CC=C1 WXNOJTUTEXAZLD-UHFFFAOYSA-L 0.000 description 1
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
• 208000034158 bleeding Diseases 0.000 description 1
• 230000000740 bleeding effect Effects 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
• 239000004327 boric acid Substances 0.000 description 1
• 208000006752 brain edema Diseases 0.000 description 1
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
• 229910052794 bromium Inorganic materials 0.000 description 1
• 125000005997 bromomethyl group Chemical group 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 235000014121 butter Nutrition 0.000 description 1
• ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
• 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 235000001046 cacaotero Nutrition 0.000 description 1
• AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
• 230000004094 calcium homeostasis Effects 0.000 description 1
• 239000000920 calcium hydroxide Substances 0.000 description 1
• 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
• 159000000007 calcium salts Chemical class 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 230000001269 cardiogenic effect Effects 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 208000015114 central nervous system disease Diseases 0.000 description 1
• 210000003710 cerebral cortex Anatomy 0.000 description 1
• 230000002490 cerebral effect Effects 0.000 description 1
• 229920001429 chelating resin Polymers 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 125000001309 chloro group Chemical group Cl* 0.000 description 1
• 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
• LNAMMBFJMYMQTO-FNEBRGMMSA-N chloroform;(1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].ClC(Cl)Cl.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 LNAMMBFJMYMQTO-FNEBRGMMSA-N 0.000 description 1
• 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
• QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
• WYYQVWLEPYFFLP-UHFFFAOYSA-K chromium(3+);triacetate Chemical compound [Cr+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WYYQVWLEPYFFLP-UHFFFAOYSA-K 0.000 description 1
• 230000002060 circadian Effects 0.000 description 1
• 229940001468 citrate Drugs 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 239000012230 colorless oil Substances 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 235000008504 concentrate Nutrition 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 238000006482 condensation reaction Methods 0.000 description 1
• 238000011443 conventional therapy Methods 0.000 description 1
• GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 1
• CGAZOROPALORNX-UHFFFAOYSA-N cyclopenta[a]naphthalen-9-one Chemical compound C1=CC2=CC=CC2=C2C(=O)C=CC=C21 CGAZOROPALORNX-UHFFFAOYSA-N 0.000 description 1
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
• 208000031513 cyst Diseases 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 231100000868 delusion Toxicity 0.000 description 1
• 229910052805 deuterium Inorganic materials 0.000 description 1
• 125000004774 dichlorofluoromethyl group Chemical group FC(Cl)(Cl)* 0.000 description 1
• BSHICDXRSZQYBP-UHFFFAOYSA-N dichloromethane;palladium(2+) Chemical compound [Pd+2].ClCCl BSHICDXRSZQYBP-UHFFFAOYSA-N 0.000 description 1
• USLKCMBGQFYUFI-UHFFFAOYSA-N dichloromethane;tribromoborane Chemical compound ClCCl.BrB(Br)Br USLKCMBGQFYUFI-UHFFFAOYSA-N 0.000 description 1
• 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
• 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
• 230000005750 disease progression Effects 0.000 description 1
• SQQYLKHXWUECGH-UHFFFAOYSA-L disodium;[9-(4-methoxyphenyl)-10-oxo-6-propoxy-2,3-dihydro-1h-pyrano[3,2-f]quinolin-7-yl]methyl phosphate Chemical compound [Na+].[Na+].CCCOC1=CC=2OCCCC=2C(C2=O)=C1N(COP([O-])([O-])=O)C=C2C1=CC=C(OC)C=C1 SQQYLKHXWUECGH-UHFFFAOYSA-L 0.000 description 1
• YRMRHTMOYAMMOV-UHFFFAOYSA-L disodium;[9-(4-methoxyphenyl)-10-oxo-6-propoxy-3,4-dihydro-2h-pyrano[2,3-f]quinolin-7-yl]methyl phosphate Chemical compound [Na+].[Na+].CCCOC1=CC=2CCCOC=2C(C2=O)=C1N(COP([O-])([O-])=O)C=C2C1=CC=C(OC)C=C1 YRMRHTMOYAMMOV-UHFFFAOYSA-L 0.000 description 1
• HFUYKHQOLBYOJK-UHFFFAOYSA-N ditert-butyl [7-(4-methoxyphenyl)-5-methyl-6-oxo-2,3-dihydrofuro[3,2-h]quinolin-9-yl]methyl phosphate Chemical compound C1=CC(OC)=CC=C1C1=CN(COP(=O)(OC(C)(C)C)OC(C)(C)C)C2=C(OCC3)C3=CC(C)=C2C1=O HFUYKHQOLBYOJK-UHFFFAOYSA-N 0.000 description 1
• VAJJEDZDZGUULP-UHFFFAOYSA-N ditert-butyl [8-(4-methoxyphenyl)-9-oxo-5-propoxy-2,3-dihydrofuro[2,3-f]quinolin-6-yl]methyl phosphate Chemical compound CCCOC1=CC=2CCOC=2C(C2=O)=C1N(COP(=O)(OC(C)(C)C)OC(C)(C)C)C=C2C1=CC=C(OC)C=C1 VAJJEDZDZGUULP-UHFFFAOYSA-N 0.000 description 1
• HCCDSKCACWLAHT-UHFFFAOYSA-N ditert-butyl [9-(4-methoxyphenyl)-10-oxo-6-propoxy-3,4-dihydro-2h-pyrano[2,3-f]quinolin-7-yl]methyl phosphate Chemical compound CCCOC1=CC=2CCCOC=2C(C2=O)=C1N(COP(=O)(OC(C)(C)C)OC(C)(C)C)C=C2C1=CC=C(OC)C=C1 HCCDSKCACWLAHT-UHFFFAOYSA-N 0.000 description 1
• LNJAJHJFSKUCIR-UHFFFAOYSA-N ditert-butyl chloromethyl phosphate Chemical compound CC(C)(C)OP(=O)(OCCl)OC(C)(C)C LNJAJHJFSKUCIR-UHFFFAOYSA-N 0.000 description 1
• MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
• 229940043264 dodecyl sulfate Drugs 0.000 description 1
• 239000000534 dopa decarboxylase inhibitor Substances 0.000 description 1
• 210000005064 dopaminergic neuron Anatomy 0.000 description 1
• 230000003291 dopaminomimetic effect Effects 0.000 description 1
• 239000008298 dragée Substances 0.000 description 1
• 239000000890 drug combination Substances 0.000 description 1
• QELUYTUMUWHWMC-UHFFFAOYSA-N edaravone Chemical compound O=C1CC(C)=NN1C1=CC=CC=C1 QELUYTUMUWHWMC-UHFFFAOYSA-N 0.000 description 1
• 229950009041 edaravone Drugs 0.000 description 1
• 230000002526 effect on cardiovascular system Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 239000002662 enteric coated tablet Substances 0.000 description 1
• 230000000925 erythroid effect Effects 0.000 description 1
• CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
• LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 1
• 150000002170 ethers Chemical class 0.000 description 1
• HHFAWKCIHAUFRX-UHFFFAOYSA-N ethoxide Chemical compound CC[O-] HHFAWKCIHAUFRX-UHFFFAOYSA-N 0.000 description 1
• DOCCDOCIYYDLGJ-UHFFFAOYSA-N ethyl 2-(4-methoxyphenyl)acetate Chemical compound CCOC(=O)CC1=CC=C(OC)C=C1 DOCCDOCIYYDLGJ-UHFFFAOYSA-N 0.000 description 1
• YTIXACRBRRYYGB-UHFFFAOYSA-N ethyl 2-[4-[5-fluoro-1-[2-(2-morpholin-4-ylethylamino)-2-oxoethyl]-4-oxo-8-propoxyquinolin-3-yl]phenoxy]acetate Chemical compound CCCOC1=CC=C(F)C(C(C(C=2C=CC(OCC(=O)OCC)=CC=2)=C2)=O)=C1N2CC(=O)NCCN1CCOCC1 YTIXACRBRRYYGB-UHFFFAOYSA-N 0.000 description 1
• DTGFVGJQXKGVNV-UHFFFAOYSA-N ethyl 2-[5-fluoro-3-(4-hydroxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]acetate Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CC(=O)OCC)C=C2C1=CC=C(O)C=C1 DTGFVGJQXKGVNV-UHFFFAOYSA-N 0.000 description 1
• AZXPMVCPNIFXSB-UHFFFAOYSA-N ethyl 2-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]acetate Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CC(=O)OCC)C=C2C1=CC=C(OC)C=C1 AZXPMVCPNIFXSB-UHFFFAOYSA-N 0.000 description 1
• BDIJGILBTIHJMM-UHFFFAOYSA-N ethyl 2-[5-fluoro-3-[4-(2-hydroxyethoxy)phenyl]-4-oxo-8-propoxyquinolin-1-yl]acetate Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CC(=O)OCC)C=C2C1=CC=C(OCCO)C=C1 BDIJGILBTIHJMM-UHFFFAOYSA-N 0.000 description 1
• ZIEMREPFEQUHCR-UHFFFAOYSA-N ethyl 2-[8-(4-methoxyphenyl)-9-oxo-5-propoxy-2,3-dihydrofuro[2,3-f]quinolin-6-yl]acetate Chemical compound CCCOC1=CC=2CCOC=2C(C2=O)=C1N(CC(=O)OCC)C=C2C1=CC=C(OC)C=C1 ZIEMREPFEQUHCR-UHFFFAOYSA-N 0.000 description 1
• CCXMIYWIKQSPNU-UHFFFAOYSA-N ethyl 2-[9-(4-methoxyphenyl)-10-oxo-6-propoxy-2,3-dihydro-1h-pyrano[3,2-f]quinolin-7-yl]acetate Chemical compound CCCOC1=CC=2OCCCC=2C(C2=O)=C1N(CC(=O)OCC)C=C2C1=CC=C(OC)C=C1 CCXMIYWIKQSPNU-UHFFFAOYSA-N 0.000 description 1
• XRAQUXUCJIBDFZ-UHFFFAOYSA-N ethyl 3-hydroxy-2-(2-methoxyphenyl)prop-2-enoate Chemical compound C(C)OC(C(=CO)C1=C(C=CC=C1)OC)=O XRAQUXUCJIBDFZ-UHFFFAOYSA-N 0.000 description 1
• XLFAVYPLCNNBJD-UHFFFAOYSA-N ethyl 4-[4-(5-fluoro-4-oxo-8-propoxy-1h-quinolin-3-yl)phenoxy]butanoate Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1NC=C2C1=CC=C(OCCCC(=O)OCC)C=C1 XLFAVYPLCNNBJD-UHFFFAOYSA-N 0.000 description 1
• NZZKCGXPTIBEFQ-UHFFFAOYSA-N ethyl 4-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]butanoate Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCCC(=O)OCC)C=C2C1=CC=C(OC)C=C1 NZZKCGXPTIBEFQ-UHFFFAOYSA-N 0.000 description 1
• YCNAKWJQXBLLNN-UHFFFAOYSA-N ethyl 4-[[5-fluoro-3-(4-methoxyphenyl)-4-oxo-1h-quinolin-8-yl]oxy]butanoate Chemical compound CCOC(=O)CCCOC1=CC=C(F)C(C2=O)=C1NC=C2C1=CC=C(OC)C=C1 YCNAKWJQXBLLNN-UHFFFAOYSA-N 0.000 description 1
• UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
• 125000004494 ethyl ester group Chemical group 0.000 description 1
• PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
• 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 238000011049 filling Methods 0.000 description 1
• 239000007941 film coated tablet Substances 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 125000001153 fluoro group Chemical group F* 0.000 description 1
• 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 description 1
• 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 235000003599 food sweetener Nutrition 0.000 description 1
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
• CYEFKCRAAGLNHW-UHFFFAOYSA-N furan-3-ylboronic acid Chemical compound OB(O)C=1C=COC=1 CYEFKCRAAGLNHW-UHFFFAOYSA-N 0.000 description 1
• 229960003980 galantamine Drugs 0.000 description 1
• ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 description 1
• 239000007903 gelatin capsule Substances 0.000 description 1
• 229940052308 general anesthetics halogenated hydrocarbons Drugs 0.000 description 1
• 239000012362 glacial acetic acid Substances 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• 235000011187 glycerol Nutrition 0.000 description 1
• 125000006343 heptafluoro propyl group Chemical group 0.000 description 1
• 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
• 210000001320 hippocampus Anatomy 0.000 description 1
• 150000004677 hydrates Chemical class 0.000 description 1
• IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
• 229930195733 hydrocarbon Natural products 0.000 description 1
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
• 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
• NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• PSCMQHVBLHHWTO-UHFFFAOYSA-K indium(iii) chloride Chemical compound Cl[In](Cl)Cl PSCMQHVBLHHWTO-UHFFFAOYSA-K 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 201000010849 intracranial embolism Diseases 0.000 description 1
• 230000000302 ischemic effect Effects 0.000 description 1
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
• 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 239000000644 isotonic solution Substances 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 229940001447 lactate Drugs 0.000 description 1
• 229910000032 lithium hydrogen carbonate Inorganic materials 0.000 description 1
• 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
• GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
• HQRPHMAXFVUBJX-UHFFFAOYSA-M lithium;hydrogen carbonate Chemical compound [Li+].OC([O-])=O HQRPHMAXFVUBJX-UHFFFAOYSA-M 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 229960003511 macrogol Drugs 0.000 description 1
• ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
• 239000001095 magnesium carbonate Substances 0.000 description 1
• 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
• VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
• 239000000347 magnesium hydroxide Substances 0.000 description 1
• 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
• 159000000003 magnesium salts Chemical class 0.000 description 1
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
• 235000019341 magnesium sulphate Nutrition 0.000 description 1
• 229940049920 malate Drugs 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• GXHFUVWIGNLZSC-UHFFFAOYSA-N meldrum's acid Chemical compound CC1(C)OC(=O)CC(=O)O1 GXHFUVWIGNLZSC-UHFFFAOYSA-N 0.000 description 1
• BUGYDGFZZOZRHP-UHFFFAOYSA-N memantine Chemical compound C1C(C2)CC3(C)CC1(C)CC2(N)C3 BUGYDGFZZOZRHP-UHFFFAOYSA-N 0.000 description 1
• 229960004640 memantine Drugs 0.000 description 1
• 206010027175 memory impairment Diseases 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 150000002736 metal compounds Chemical class 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
• 229940098779 methanesulfonic acid Drugs 0.000 description 1
• UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
• SOUZVNRETLFIPJ-UHFFFAOYSA-N methyl 3-[2-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]ethylsulfonyl]propanoate Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1N(CCS(=O)(=O)CCC(=O)OC)C=C2C1=CC=C(OC)C=C1 SOUZVNRETLFIPJ-UHFFFAOYSA-N 0.000 description 1
• LDTLDBDUBGAEDT-UHFFFAOYSA-N methyl 3-sulfanylpropanoate Chemical compound COC(=O)CCS LDTLDBDUBGAEDT-UHFFFAOYSA-N 0.000 description 1
• QUXANKSEVWSDNT-UHFFFAOYSA-N methyl 5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxy-1h-quinoline-2-carboxylate Chemical compound CCCOC1=CC=C(F)C(C2=O)=C1NC(C(=O)OC)=C2C1=CC=C(OC)C=C1 QUXANKSEVWSDNT-UHFFFAOYSA-N 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 150000004702 methyl esters Chemical class 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 235000010981 methylcellulose Nutrition 0.000 description 1
• 208000012268 mitochondrial disease Diseases 0.000 description 1
• 230000001333 moisturizer Effects 0.000 description 1
• 230000003020 moisturizing effect Effects 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• 206010028320 muscle necrosis Diseases 0.000 description 1
• 239000003703 n methyl dextro aspartic acid receptor blocking agent Substances 0.000 description 1
• OCNQVVIXVRNCGS-UHFFFAOYSA-N n-(3-propoxy-5,6,7,8-tetrahydronaphthalen-2-yl)acetamide Chemical compound C1CCCC2=C1C=C(OCCC)C(NC(C)=O)=C2 OCNQVVIXVRNCGS-UHFFFAOYSA-N 0.000 description 1
• GWSSCECXYRHBTG-UHFFFAOYSA-N n-[1-(3-propoxy-5,6,7,8-tetrahydronaphthalen-2-yl)ethylidene]hydroxylamine Chemical compound C1CCCC2=C1C=C(OCCC)C(C(C)=NO)=C2 GWSSCECXYRHBTG-UHFFFAOYSA-N 0.000 description 1
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
• 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 230000008693 nausea Effects 0.000 description 1
• 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 210000001577 neostriatum Anatomy 0.000 description 1
• 208000033510 neuroaxonal dystrophy Diseases 0.000 description 1
• 230000000626 neurodegenerative effect Effects 0.000 description 1
• 210000002682 neurofibrillary tangle Anatomy 0.000 description 1
• 230000009251 neurologic dysfunction Effects 0.000 description 1
• 208000015015 neurological dysfunction Diseases 0.000 description 1
• 239000004090 neuroprotective agent Substances 0.000 description 1
• 229910052759 nickel Inorganic materials 0.000 description 1
• 229910000480 nickel oxide Inorganic materials 0.000 description 1
• 210000001328 optic nerve Anatomy 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 230000036542 oxidative stress Effects 0.000 description 1
• 150000002923 oximes Chemical class 0.000 description 1
• GNRSAWUEBMWBQH-UHFFFAOYSA-N oxonickel Chemical compound [Ni]=O GNRSAWUEBMWBQH-UHFFFAOYSA-N 0.000 description 1
• HBEQXAKJSGXAIQ-UHFFFAOYSA-N oxopalladium Chemical compound [Pd]=O HBEQXAKJSGXAIQ-UHFFFAOYSA-N 0.000 description 1
• MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 229910003445 palladium oxide Inorganic materials 0.000 description 1
• MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
• PBDBXAQKXCXZCJ-UHFFFAOYSA-L palladium(2+);2,2,2-trifluoroacetate Chemical compound [Pd+2].[O-]C(=O)C(F)(F)F.[O-]C(=O)C(F)(F)F PBDBXAQKXCXZCJ-UHFFFAOYSA-L 0.000 description 1
• NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
• LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
• YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
• JKDRQYIYVJVOPF-FDGPNNRMSA-L palladium(ii) acetylacetonate Chemical compound [Pd+2].C\C([O-])=C\C(C)=O.C\C([O-])=C\C(C)=O JKDRQYIYVJVOPF-FDGPNNRMSA-L 0.000 description 1
• INIOZDBICVTGEO-UHFFFAOYSA-L palladium(ii) bromide Chemical compound Br[Pd]Br INIOZDBICVTGEO-UHFFFAOYSA-L 0.000 description 1
• 230000001898 pallidal effect Effects 0.000 description 1
• 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
• 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
• 125000005005 perfluorohexyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)* 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• 229940075930 picrate Drugs 0.000 description 1
• OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
• 229910003446 platinum oxide Inorganic materials 0.000 description 1
• 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
• 239000004584 polyacrylic acid Substances 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 159000000001 potassium salts Chemical class 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 238000004393 prognosis Methods 0.000 description 1
• 206010036807 progressive multifocal leukoencephalopathy Diseases 0.000 description 1
• 229960002429 proline Drugs 0.000 description 1
• BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
• QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
• 229940080818 propionamide Drugs 0.000 description 1
• NBBJYMSMWIIQGU-UHFFFAOYSA-N propionic aldehyde Natural products CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 1
• 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 125000001453 quaternary ammonium group Chemical group 0.000 description 1
• LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical group C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
• VSGPVHSTVTXREH-UHFFFAOYSA-N quinolin-4-one Chemical compound C1=CC=C[C]2C(=O)C=CN=C21 VSGPVHSTVTXREH-UHFFFAOYSA-N 0.000 description 1
• 125000004550 quinolin-6-yl group Chemical group N1=CC=CC2=CC(=CC=C12)* 0.000 description 1
• 229940044551 receptor antagonist Drugs 0.000 description 1
• 239000002464 receptor antagonist Substances 0.000 description 1
• 230000000306 recurrent effect Effects 0.000 description 1
• 230000001603 reducing effect Effects 0.000 description 1
• 238000007363 ring formation reaction Methods 0.000 description 1
• 229960004136 rivastigmine Drugs 0.000 description 1
• HKIKNSGIKDEKGP-UHFFFAOYSA-N s-[2-(dimethylamino)ethyl] 3-[5-fluoro-3-(4-methoxyphenyl)-4-oxo-8-propoxyquinolin-1-yl]propanethioate;hydrochloride Chemical compound Cl.CCCOC1=CC=C(F)C(C2=O)=C1N(CCC(=O)SCCN(C)C)C=C2C1=CC=C(OC)C=C1 HKIKNSGIKDEKGP-UHFFFAOYSA-N 0.000 description 1
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
• ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
• 239000004208 shellac Substances 0.000 description 1
• 235000013874 shellac Nutrition 0.000 description 1
• 229940113147 shellac Drugs 0.000 description 1
• 235000020374 simple syrup Nutrition 0.000 description 1
• XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
• 238000009097 single-agent therapy Methods 0.000 description 1
• 235000010413 sodium alginate Nutrition 0.000 description 1
• 239000000661 sodium alginate Substances 0.000 description 1
• 229940005550 sodium alginate Drugs 0.000 description 1
• UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
• 229960002218 sodium chlorite Drugs 0.000 description 1
• BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
• 229940074545 sodium dihydrogen phosphate dihydrate Drugs 0.000 description 1
• 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
• 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 235000011008 sodium phosphates Nutrition 0.000 description 1
• 159000000000 sodium salts Chemical class 0.000 description 1
• AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
• 235000019345 sodium thiosulphate Nutrition 0.000 description 1
• 239000007901 soft capsule Substances 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 230000007480 spreading Effects 0.000 description 1
• 238000003892 spreading Methods 0.000 description 1
• 210000003523 substantia nigra Anatomy 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 239000007940 sugar coated tablet Substances 0.000 description 1
• 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 210000000225 synapse Anatomy 0.000 description 1
• 230000005062 synaptic transmission Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 125000006253 t-butylcarbonyl group Chemical group [H]C([H])([H])C(C(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• 229940095064 tartrate Drugs 0.000 description 1
• 238000003419 tautomerization reaction Methods 0.000 description 1
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• 150000004685 tetrahydrates Chemical class 0.000 description 1
• 229940126585 therapeutic drug Drugs 0.000 description 1
• 229910052718 tin Inorganic materials 0.000 description 1
• 239000011135 tin Substances 0.000 description 1
• 235000010487 tragacanth Nutrition 0.000 description 1
• 239000000196 tragacanth Substances 0.000 description 1
• 229940116362 tragacanth Drugs 0.000 description 1
• 125000005270 trialkylamine group Chemical group 0.000 description 1
• 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
• 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• COIOYMYWGDAQPM-UHFFFAOYSA-N tris(2-methylphenyl)phosphane Chemical compound CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C COIOYMYWGDAQPM-UHFFFAOYSA-N 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
• 229920002554 vinyl polymer Polymers 0.000 description 1
• 238000010792 warming Methods 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical class [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1